Rubin 5e Suggested Readings P. 1 of 97
Chapter 1
Baldwin KM, Haddad F: Skeletal muscle plasticity: Cellular and molecular responses to altered physical activity paradigms. Am J Phys Med Rehabil 81:S40–51, 2002.
Bohr VA: Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 32:804–812, 2002.
Copin MC, Buisine MP, Devisme L, et al.: Normal respiratory mucosa, precursor lesions and lung carcinomas: Differential expression of human mucin genes. Frontiers Biosci
6:D1264–1275, 2001.
Faragher RG: Cell senescence and human aging: Where’s the link? Biochem Soc Trans
28:221–226, 2000.
Farout L, Friguet B: Proteasome function in aging and oxidative stress: Implications in protein maintenance failure. Antiox Redox Signal 8:205–216, 2006.
Giffard RG, Xu L, Zhao H, et al.: Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J Exp Biol 207:3213–3220, 2004.
Glass DJ: Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat
Cell Biol 5:87–90, 2003.
Granger MP, Wright WE, Shay JW: Telomerase in cancer and aging. Crit Rev Oncol
Hematol 41:29–40, 2002.
Greider CW: Cellular responses to telomere shortening: Cellular senescence as a tumor suppressor mechanism. Harvey Lectures 96:33–50, 2000–2001.
Harkema JR, Wagner JG: Non-allergic models of mucous cell metaplasia and mucus hypersecretion in rat nasal and pulmonary airways. Novartis Found Symp 248:181–197,
2002. Rubin 5e Suggested Readings P. 2 of 97
Henry CJ: Mechanisms of changes in basal metabolism during ageing. Eur J Clin Nutr
54:S77–91, 2000.
Higami Y, Shimokawa I: Apoptosis in the aging process. Cell Tissue Res 301:125–132,
2000.
Hodes RJ, Hathcock KS, Weng NP: Telomeres in T and B cells. Immunology 2:699–706,
2002.
Holleyman CR, Larson DF. Apoptosis in the ischemic reperfused myocardium. Perfusion
16:491–502, 2001.
Hursting SD, Lavigne JA, Berrigan D, et al.: Calorie restriction, aging, and cancer prevention: Mechanisms of action and applicability to humans. Annu Rev Med 54:131–
52, 2003.
Iverson SL, Orrenius S: The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 423:37–46, 2004.
Jaeschke H: Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Amer J Physiol: Gastrointest Liver Physiol 284:G15–26, 2003.
Jaeschke H, Knight TR, Bajt ML: The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Letts 144:279–288, 2003.
Jassem W, Fuggle SV, Rela M, et al.: The role of mitochondria in ischemia/reperfusion injury. Transplantation 73:493–499, 2002.
Jenkins GJ, Doak SH, Parry JM, et al.: Genetic pathways involved in the progression of
Barrett’s metaplasia to adenocarcinoma. Br J Surg 89:824–837, 2002.
Kaminski KA, Bonda TA, Korecki J, et al.: Oxidative stress and neutrophil activation:
The two keystones of ischemia/reperfusion injury. Int J Cardiol 86:41–59, 2002. Rubin 5e Suggested Readings P. 3 of 97
Keller JN, Dimayuga E, Chen Q, et al.: Autophagy, proteasomes, lipofucsin, and
oxidative stress in the aging brain. Int J Biochem Cell Biol 36:2376–2391, 2004.
Kolesnick R, Fuks Z: Radiation and ceramide-induced apoptosis. Oncogene 22:5897–
5906, 2003.
Kowald A: The mitochondrial theory of aging. Biol Signals Receptors 10:162–175,
2001.
Kukan M: Emerging roles of proteasomes in ischemia-reperfusion injury of organs. J
Physiol Pharmacol 55:3–15, 2004.
Lalu MM, Wang W, Schulz R: Peroxynitrite in myocardial ischemia-reperfusion injury.
Heart Fail Rev 7:359–369, 2002.
Lawen A: Apoptosis: An introduction. Bioessays 25:888–896, 2003.
Li C, Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Amer J Physiol Cell Physiol 282:C227–241, 2002.
Liaudet L, Szabo G, Szabo C: Oxidative stress and regional ischemia-reperfusion injury:
The peroxynitrite-poly(ADP-ribose) polymerase connection. Coron Artery Dis 14:115–
122, 2003.
McBride WH, Iwamoto KS, Syljuasen R, et al.: The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene 22:5755–5773, 2003.
Mentzer RM Jr, Lasley RD, Jessel A, et al.: Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. Ann Thorac Surg 75:S700–708, 2003.
Murphy E, Cross HR, Steenbergen C: Is Na/Ca exchange during ischemia and reperfusion beneficial or detrimental? Ann NY Acad Sci 976:421–430, 2002. Rubin 5e Suggested Readings P. 4 of 97
Nieminen AL: Apoptosis and necrosis in health and disease: Role of mitochondria. Int
Rev Cytol 224:29–55, 2003.
Ostler EL, Wallis CV, Sheerin AN, et al.: A model for the phenotypic presentation of
Werner’s syndrome. Exp Gerontol 37:285–292, 2002.
Piper HM, Meuter K, Schafer C: Cellular mechanisms of ischemia-reperfusion injury.
Ann Thorac Surg 75:S644–648, 2003.
Rao RV, Bredesen DE: Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 16:653–662, 2004.
Reid MB: Response of the ubiquitin-proteasome pathway to changes in muscle activity.
Am J Physiol Regul Integr Comp Physiol 228:R1423–R1431, 2005.
Rensing L, Meyer-Grahle U, Ruoff P: Biological timing and the clock metaphor:
Oscillatory and hourglass mechanisms. Chronobiol Int 18:329–369, 2001.
Ryazanov AG, Nefsky BS: Protein turnover plays a key role in aging. Mech Ageing Dev
123:207–213, 2002.
Sack MN, Yellon DM: Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: A proposed direct myocardial cell survival effect independent of metabolic modulation. J Amer Coll Cardiol 41:1404–1407, 2003.
Salvemini D, Cuzzocrea S: Superoxide, superoxide dismutase and ischemic injury. Curr
Opin Invest Drugs 3:886–895, 2002.
Saretzki G, Von Zglinicki T: Replicative aging, telomeres, and oxidative stress. Ann NY
Acad Sci 959:24–29, 2002.
Sax JK, El-Deiry WS: p53 downstream targets and chemosensitivity. Cell Death Diff
10:413–417, 2003. Rubin 5e Suggested Readings P. 5 of 97
Schmidt-Ullrich RK, Dent P, Grant S, et al.: Signal transduction and cellular radiation
responses. Radiat Res 153:245–257, 2000.
Schultz DR, Harrington WJ Jr: Apoptosis: Programmed cell death at a molecular level.
Semin Arthritis Rheum 32:345–369, 2003.
Shearer MJ: Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis
and vascular calcification. Curr Opin Clin Nutr Metab Care 3:433–438, 2000.
Sohal RS: Role of oxidative stress and protein oxidation in the aging process. Free Radic
Biol Med 33:37–44, 2002.
Squier TC: Oxidative stress and protein aggregation during biological aging. Exp
Gerontol 36:1539–1550, 2001.
Steensma DP, Timm M, Witzig TE: Flow cytometric methods for detection and
quantification of apoptosis. Meth Mol Med 85:323–332, 2003.
Tabner BJ, El-Agnaf OMA, German MJ, et al.: Protein aggregation, metals and oxidative
stress in neurodegenerative diseases. Biochem Soc Trans 33:1082–1086, 2005.
Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals.
Science 299:1346–1351, 2003.
Thompson LH, Schild D: Recombinational DNA repair and human disease. Mutat Res
509:49–78, 2002.
Walter L, Miyoshi H, Leverve X, et al.: Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report. Free Rad Res 36:405–412,
2002.
Wymann MP, Zvelebil M. Laffargue M: Phosphoinositide 3-kinase signalling: Which way to target? Trends Pharmacol Sci 24:366–376, 2003. Rubin 5e Suggested Readings P. 6 of 97
Yoshida H: The role of Apaf-1 in programmed cell death: From worm to tumor. Cell
Struct Funct 28:3–9, 2003.
Yu BP, Lim BO, Sugano M: Dietary restriction downregulates free radical and lipid peroxide production: Plausible mechanism for elongation of life span. J Nutr Sci
Vitaminol 48:257–264, 2002.
Yuasa Y: DNA methylation in cancer and ageing. Mech Ageing Dev 123:1649–1654,
2002.
Chapter 2
Books
Collins T: Leukocyte recruitment, endothelial cell adhesion molecules, and
transcriptional control: Insights for drug discovery. Philadelphia: Kluwer, 2001.
Cronstein BN, Weissmann G, Koch A, et al.: Inflammation. Philadelphia: Kluwer, 2004.
Gallin JI, Synderman R, Fearon DT, et al.: Inflammation: Basic oprinciples and clinical
correlates. Philadelphia: Lippincott Williams & Wilkins, 1999.
Gorski A, Krotkiewski H, Zimecki M: Inflammation. Philadelphia: Kluwer, 2001.
Honn KV, Marnett LJ, Nigam S, et al.: Eicosanoids and other bioactive lipids in cancer, inflammation, and radiation injury. Philadelphia: Kluwer, 2003.
Ley K: Physiology of inflammation. Bethesda, MD: American Physiological Society,
2001.
Pearson JD: Vascular adhesion molecules and inflammation. New York: Springer-
Verlag, 2002. Rubin 5e Suggested Readings P. 7 of 97
Salvemini D, Billiar TM, Vodovotz Y: Nitric oxide and inflammation. Boston:
Birkhauser, 2001.
Van Eden W: Heat shock proteins and inflammation research. Boston: Birkhauser, 2004.
Whicher JT, Evans SW: Biochemistry of inflammation. Philadelphia: Kluwer
Academic/Plenum, 1992.
Winyard PD, Evans BC: Free radicals in inflammation. Boston: Birkhauser, 2004.
Yazici Z, Folco GC, Drazen JM, et al.: Advances in prostaglandin, leukotriene and other
bioactive lipid research: Basic science and clinical applications. Philadelphia: Kluwer,
2003.
Review Articles
Baggiolini M: Chemokines in pathology and medicine. J Intern Med 250:91, 2001.
Biedermann BC: Vascular endothelium: Checkpoint for inflammation and immunity.
News Physiol Sci 16:84, 2001.
Booth JW, Trimble WS, Grinstein S: Membrane dynamics in phagocytosis. Semin
Immunol 13:357, 2001.
Bornstein P, Sage EH: Matricellular proteins: Extracellular modulators of cell function.
Curr Opin Cell Biol 14:608, 2002.
Buckley CD, Pilling D, Lord JM, et al.: Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 22:199, 2001.
Co DO, Hogana LH , Il-Kim S, et al.: T cell contributions to the different phases of granuloma formation. Immunol Letts 92:135, 2004. Rubin 5e Suggested Readings P. 8 of 97
De Maio A, Torres MB, Reeves RH: Genetic determinant influencing the response to
injury, inflammation and sepsis. Shock 23:11, 2005.
Fitzgerald GA, Loll P: Cox in a crystal ball: Current status and future premise of
Prostaglandin. J Clin Invest 107:1335, 2001.
Grisham MB, Jourd’heuil D, Wink DA: Review article: Chronic inflammation and
reactive oxygen and nitrogen metabolism—implications in DNA damage and
mutagenesis. Alimentary Pharmacol Ther 14:3, 2000.
Hanada T, Yoshimura A: Regulation of cytokine signaling and inflammation. Cytokine
Growth Factor Rev 13:413, 2002.
Ley K: Pathways and bottlenecks in the web of inflammatory adhesion molecules and
chemoattractants. Immunol Res 24:87, 2001.
McIntyre TM, Prescott SM, Weyrich AS, et al.: Cell-cell interactions: Leukocyte-
endothelial interactions. Cur Opin Hematol 10:150, 2003.
Nussler AK, Wittel UA, Nussler NC, et al.: Leukocytes: The Janus cells in inflammatory
disease. Langenbecks Arch Surg 384:222, 1999.
Rossi D, Zlotnik A: The biology of chemokines and their receptors. Ann Rev Immunol
18:217, 2000.
Sears MR: Consequences of long-term inflammation. The natural history of asthma. Clin
Chest Med 21:315, 2000.
Steeber DA, Tedder TF: Adhession molecule cascades direct lymphocyte recirculation
and leukocyte migration during inflammation. Immunol Res 22:299, 2001. Rubin 5e Suggested Readings P. 9 of 97
Vaday GG, Franitza S, Schor H, et al.: Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leuk Biol
69:885, 2001.
Walport MJ: Complement I. N Engl J Med 344:1058, 2001.
Walport MJ: Complement II. N Engl J Med 344:1140, 2001.
Watts C, Amigorena S: Phagocytosis and antigen presentation. Semin Immunol 13:373,
2001.
Willoughby DA, Moore AR, Colville-Nash PR, et al.: Resolution of inflammation. Int J
Immunopharmacol 22:1131, 2000.
Yoshie O: Role of chemokines in trafficking of lymphocytes and dendritic cells. Int J
Hematol 72:399, 2000.
Chapter 3
Books
Fine NA, Mustoe TA: Wound healing. In: Greenfield LJ, Mulholland MW, Oldham KT, et al. (eds). Surgery: Scientific principles and practice, 3rd ed. Philadelphia: Lippincott
Williams & Wilkins, 2005:69–85.
Royce PM, Steinman B: Connective tissue and its heritable disorders: Molecular, genetic, and medical aspects, 2nd ed. New York: Wiley-Liss, 2002.
Falanga V: Cutaneous wound healing, 1st ed. London: Martin Dunitz, 2001. Rubin 5e Suggested Readings P. 10 of 97
Review Articles
Baksh D, Song L, Tuan RS: Adult mesenchymal stem cells: Characterization,
differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301–316,
2004.
Diegelmann RF, Evans MC: Wound healing: An overview of acute, fibrotic and delayed healing. Frontiers Biosci 9:283–289, 2004.
Eckfeldt CE, Mendenhall EM, Verfaillie CM: The molecular repertoire of the ‘almighty’ stem cell. Nat Rev 6:726–737, 2005.
Even-Ram S, Yamada KM: Cell migration in 3D matrix. Curr Opin Cell Biol 17:524–
532, 2005.
Ferguson WJ, O’Kane S: Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Phil Trans R. Soc Lond B 359:839–850, 2004.
Ffrench-Constant C, Colognato H: Integrins: Versatile integrators of extracellular signals.
Trends Cell Biol 14:678–686, 2004.
Fini ME, Stramer BM: How the cornea heals. Cornea-specific repair mechanisms affecting surgical outcomes. Cornea 24:S2–S11, 2005.
Fu X, Li X, Cheng B, et al.: Engineered growth factors and cutaneous wound healing:
Success and possible questions in the past 10 years. Wound Rep Reg 13:122–130, 2005.
Hintermann E, Quaranta V: Epithelial cell motility on laminin-5: Regulation by matrix assembly, proteoloysis, integrins and erb B receptors. Matrix Biol 23:75–85, 2004
Martin P, Leibovich JS: Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 15:599–607, 2005. Rubin 5e Suggested Readings P. 11 of 97
Metz CN: Fibrocytes: A unique cell population implicated in wound healing. Cell Mol
Life Sci 60:1342–1350, 2003.
Miner JH, Yurchenko PD: Laminin functions in tissue morphogenesis. Annu Rev Cell
Dev Biol 20:255–284, 2004.
Mott JD, Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin
Cell Biol 16:558–564, 2004.
Myllyharju J, Kivirikko KI: Collagens, modifying enzymes and their mutations in
humans, flies and worms. Trends Genet 20:33–43, 2004.
Pozzi A, Zent R: Integrins: Sensors of extracellular matrix and modulators of cell
function. Nephron Exp Nephrol 94:e77–84, 2003.
Rizvi AZ, Wong MH: Epithelial stem cells and their niche: There’s no place like home.
Stem Cells 23:150–165, 2005.
Schultz G, Sibbald RG, Falanga V, et al: Wound bed preparation: A systemic approach to
wound management. Wound Rep Reg 11:1–28, 2003.
Shizuru JA, Negrin RS, Weissman IL: Hematopoietic stem and progenitor cells: Clinical
and preclincial regeneration of the hematolymphoid system. Annu Rev Med 56:509–538,
2005.
Singer AJ, Clark RAF: Cutaneous wound healing. N Engl J Med 341:738–746, 1999.
Steed DL: Wound healing. Surg Clin North Am 83:2003.
Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev
Cell Dev Biol 17:463–516, 2001.
Watt SM, Fox A: Blood vessel stem cells and wound healing. Br J Surg 92:1461–1463,
2005. Rubin 5e Suggested Readings P. 12 of 97
Chapter 4
Books
Ochs HL, Smith CIE, Puck JM: Primary immunodeficiency diseases: A molecular and
genetic approach, 1st ed. New York: Oxford University Press, 1999.
Paul WE: Fundamental immunology, 5th ed. Philadelphia: Lippincott Williams &
Wilkins, 2003.
Rich RR, Fleisher TA, Shearer WT, et al.: Clinical immunology: Principles and practice,
2nd ed. London: Mosby, 2001.
Review Articles
Buckley RH: Primary immunodeficiency diseases: Dissectors of the immune system.
Immunobiol Rev 185:206, 2002.
Donnelly AM, et al.: Discoid lupus erythematosus. Austr J Dermatol 36:3, 1995.
Finzi D, Blankson J, Siliciano JD, et al.: Latent infection of CD4+ T cells provides a
mechanism for lifelong persistence of HIV-1, even in patients on effective combination
therapy. Nature Med 5:512–517, 1999.
Fox RI, Stern M, Michelson P: Update in Sjögren syndrome. Curr Opin Rheumatol
12:391, 2000.
Gould HJ, et al.: The biology of IgE and the basis of allergic disease. Annu Rev Immunol
21:579, 2003.
Hoffman RW, Greidinger EL: Mixed connective tissue disease. Curr Opin Rheumatol
12:386, 2000. Rubin 5e Suggested Readings P. 13 of 97
Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 20:197,
2002.
Kahaleh MB, LeRoy EC: Autoimmunity and vascular involvement in systemic sclerosis
(SSc). Autoimmunity 31:195, 1999.
Levine JS, Branch DW, Rauch J: The anti-phospholipid syndrome. N Engl J Med
346:752, 2002.
Marrack P, Kappler J, Kotzin BL: Autoimmune disease: Why and where it occurs. Nat
Med 7:899, 2001.
Marsden VA, Strasser A: Control of apoptosis in the immune system. Ann Rev Immunol
21:71, 2003.
McDermid HE, Morrow BE: Genomic disorders on 22q11. Am J Hum Genet 70:1077,
2002.
Mebius RE: Organogenesis of lymphoid tissues. Nat Rev Immurol 3:292, 2003.
Mellman I, Steinman RM: Dendritic cells: Specialized and regulated antigen processing
machines. Cell 106:255, 2001.
Murphy KM, Reiner SL: The lineage decisions of helper T cells. Nat Rev Immunol 2:933,
2002.
Patel P, Werth V: Cutaneous lupus erythematosus: A review. Dermatol Clin 20:373,
2002.
Pillay D, Taylor S, Richman DD: Incidence and impact of resistance against approved
antiretroviral drugs. Rev Med Virol 10:231–253, 2000.
Rubin RL: Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol
11:357, 1999. Rubin 5e Suggested Readings P. 14 of 97
Ruiz-Irastorza G, et al.: Systemic lupus erythematosus. Lancet 357:1027, 2001.
Russell JH, Ley TJ: Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20:323,
2002.
Scaletti C, et al: Microchimerism and systemic sclerosis. Int Arch Allergy Immunol
125:196, 2001.
Schwartz RH: T cell anergy. Ann Rev Immunol 21:305, 2003.
Takeda K, Kaisho T, Akira S: Toll-like receptors. Ann Rev Immunol 21:335, 2003.
Vogelsang GB, Lee L, Bensen-Kennedy DM: Pathogenesis and treatment of graft-versus- host disease after bone marrow transplant. Annu Rev Med 54:29, 2003.
Walker LS, Abbas AK: The enemy within: keeping self-reactive T cells at bay in the
periphery. Nat Rev Immunol 2:11, 2002.
Wensig AM, Boucher CA: Worldwide transmission of drug-resistant HIV. AIDS Rev
5:140–155, 2003.
Chapter 5
Books
Atlases of tumor pathology. Armed Forces Institute of Pathology.
Dabbs D: Diagnostic immunohistochemistry. New York: Churchill-Livingstone, 2006.
Devita VT Jr, Hellman S, Rosenberg A: Cancer: Principles and practice of oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2004.
Mills SE: Sternberg’s diagnostic surgical pathology. Philadelphia: Lippincott Williams
& Wilkins, 2004.
Rosai J: Surgical pathology. Toronto: Mosby, 2004 Rubin 5e Suggested Readings P. 15 of 97
Souhami RL, Tannock I, Hohenberger P, et al.: Oxford textbook of oncology. Oxford,
MA: Oxford University Press, 2002.
Vogelstein B, Kinzler KW: The genetic basis of human cancer. New York: McGraw-
Hill, 2002.
Review Articles
Al-Hajj M, Clarke MF: Self-renewal and solid tumor stem cells. Oncogene 23:7274–
7282, 2004.
Aplan PD: Causes of oncogenic chromosomal translocation. Trends Genet 22:46–55,
2006.
Blume-Jensen P, Hunter T: Oncogenic kinase signaling. Nature 411:355–365, 2001.
Brakebusch C, Bouvard D, Stanchi F, et al.: Integrins in invasive growth. J Clin Invest
109:999–1006, 2002.
Calvert PM, Frucht H: The genetics of colorectal cancer. Ann Intern Med 137:603–612,
2002.
Corn PG, El-Deiry WS: Derangement of growth and differentiation control in oncogenesis. BioEssays 24:83–90, 2002.
Esteller M: Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94:179–183, 2006.
Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 4:342–
348, 2001.
Folkman J: Angiogenesis. Annu Rev Med 57:1–18, 2006. Rubin 5e Suggested Readings P. 16 of 97
Feinberg AP, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer.
Nat Rev Genet 7:21–33, 2006.
Hahn WC, Weinberg RA: Rules for making tumor cells. N Engl J Med 347:1593–1603,
2002.
Hickman JA: Apoptosis and tumourigenesis. Curr Opin Genet Dev 12:67–72, 2002.
Jaffer S, Bleiweiss IJ: Beyond hematoxylin and eosin: The role of immunohistochemistry
in surgical pathology. Cancer Invest 22:445–465, 2004.
Jemal A, Murray T, Samuels A, et al.: Cancer 53:5–26, 2003.
Jiang T, Goldberg ID, Shi YE: Complex roles of tissue inhibitors of metalloproteinases in
cancer. Oncogene 21:2245–2252, 2002.
Marsh DJ, Zori RT: Genetic insights into familial cancers: Update and recent discoveries.
Cancer Lett 181:125–164, 2002.
Munger K: Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest 20:71–81, 2002.
Payne SR, Kemp CJ: Tumor suppressor genetics. Carcinogenesis 26:2031–2045, 2005.
Sen F, Vega F, Medeiros J: Molecular methods in the diagnosis of hematologic neoplasms. Semin Diagn Pathol 19:72–93, 2002.
Soussi T, Lozano G: p53 mutation heterogeneity in cancer. Biochem Biophys Res
Commun 331:834–842, 2005.
Talbot SJ, Crawford DH: Viruses and tumours: An update. Eur J Cancer 40:1998–2005,
2004
Turnbull C, Hodgson S: Genetic predisposition to cancer. Clin Med 5:491–498, 2005. Rubin 5e Suggested Readings P. 17 of 97
Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med
10:789–799, 2004.
White MK, McCubrey JA: Suppression of apoptosis: Role in cell growth and neoplasia.
Leukemia 15:1011–1021, 2001.
Chapter 6
Behrman RE, Kliegman RM, Arvin AM: Nelson’s textbook of pediatrics, 16th ed.
Philadelphia: WB Saunders, 2000.
Killeen AA: Principles of molecular pathology. Totowa, NJ: Humana Press, 2003.
Nussbaum RL, McInnes RR, Willard HF: Thompson & Thompson genetics in medicine,
6th ed. Philadelphia: WB Saunders, 2004.
Scriver CR, Sly WS, Childs B, et al.: The metabolic and molecular basis of inherited
disease, 8th ed. New York: McGraw-Hill, 2000.
Review Articles
Anonymous: ACOG practice bulletin. Clinical management guidelines for obstetricians-
gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol
97: 2001.
Anonymous: National Institutes of Health Consensus Development Conference
Statement: Phenylketonuria screening and management. Pediatrics 108:972–982, 2001.
Dimauro S, Davidzon G: Mitochondrial DNA and disease. Ann Med 37:222–232, 2005.
Eichholzer M, Tonz O, Zimmermann R: Folic acid: A public health challenge. Lancet
367:1352–1361, 2006 Rubin 5e Suggested Readings P. 18 of 97
Gadsby DC, Vergani P, Csanady L: The ABC protein turned chloride channel whose
failure causes cystic fibrosis. Nature 440:477–483, 2006.
Gartler SM, Goldman MA: Biology of the X chromosome. Curr Opin Pediatr 13:340–
345, 2001.
Gelineau-van Waes J, Finnell RH: Genetics of neural tube defects. Semin Pediatr Neurol
8:160–164, 2001.
Grahame R. Heritable disorders of connective tissue. Ballieres Best Pract Res Clin
Rheumatol 14:345–361, 2000.
Graw J, Brackmann HH, Oldenburg J, et al.: Hemophilia A from mutation analyss to new therapies. Nat Rev Genet 6:488–501, 2005
Hansis C, Grifo J: Tay-Sachs disease and preimplantation genetic diagnosis. Adv Genet
44:311–315, 2001.
Hassold T, Hunt P: To err (meiotically) is human: The genesis of human aneuploidy. Natl
Rev Genet 2:280–291, 2001.
Horsthemke B, Buiting K: Imprinting defects on human chromosome 15. Cytogenet
Genome Res 113:292–299, 2006
Kinsella JP, Greenough A, Abman SH: Bronchopulmonary dysplasia. Lancet 367:1421–
1431, 2006.
Mahenthiralingam E, Baldwin A, Vandamme P: Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 51:533–538, 2002.
Nagler J: Sudden infant death syndrome. Curr Opin Pediatr 14:247–250, 2002.
Ozawa E, Yoshida M, Suzuki A, et al.: Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 4:1711–1716, 1995. Rubin 5e Suggested Readings P. 19 of 97
Pearson CE, Nichol Edamura K, Cleary JD: Repeat instability: Mechanisms of dynamic mutations. Nat Rev Genet 6:729-742, 2005.
Polifka JE, Friedman JM: Medical genetics: 1. Clinical teratology in the age of genomics.
Can Med Assoc J 167:265–273, 2002.
Ranum LP, Day JW: Myotonic dystrophy: RNA pathogenesis comes into focus. Am J
Hum Genet 74:793–804, 2004.
Robertson KD: DNA methylation and human disease. Nat Rev Genet 6:597–610, 2005.
Scriver CR: Garrod’s foresight; our hindsight. J Inherit Metab Dis 24:93–116, 2001.
Sherman SL, Freeman SB, Allen EG, et al.: Risk factors for nondisjunction of trisomy
21. Cytogenet Genome Res 111:273–280, 2005
Spitzer AR: Current controversies in the pathophysiology and prevention of sudden infant death syndrome. Curr Opin Pediatr 17:181–185, 2005.
Suresh GK, Soll RF: Overview of surfactant replacement trials. J Perinatol 25:S40–S44,
2005.
Thackray H, Tifft C: Fetal alcohol syndrome. Pediatr Rev 22:47–55, 2001.
Yohay K. Neurofibormatosis types 1 and 2. Neurologist 12:86–93, 2006.
Chapter 7
Books
Braunwald E: Heart disease: A textbook of cardiovascular medicine, 5th ed.
Philadelphia: WB Saunders, 1997.
Hall JB, Schmidt GA, Wood LDH: Principles of critical care, 2nd ed. New York:
McGraw-Hill, 1998. Rubin 5e Suggested Readings P. 20 of 97
Kelley WN: Textbook of internal medicine, 3rd ed. Philadelphia: Lippincott-Raven, 1997.
Silver MD, Gotlieb AI, Schoen FJ: Cardiovascular pathology, 3rd ed. Amsterdam:
Churchill-Livingstone, 2001.
Virmani R, Burke A, Farb A, et al.: Cardiovascular pathology. Philadelphia: WB
Saunders, 2001.
Review Articles
Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunctional
syndrome. Blood 101:3765–3777, 2003.
Aldridge AJ: Role of the neutrophil in septic shock and the adult respiratory distress
syndrome. Europ Surg 168:204–214, 2002.
Bateman RM, Sharpe MD, Ellis CG: Bench-to-bedside review: Microvascular
dysfunction in sepsis—hemodynamics, oxygen transport, and nitric oxide. Crit Care
7:359–373, 2003.
Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory
response syndrome: What we do and do not know about cytokine regulation. Crit Care
Med 24:163–172, 1996.
Ceppa EP, Fuh KC, Bulkley GB: Mesenteric hemodynamic response to circulatory
shock. Curr Opin Crit Care 9:127–132, 2003.
Deutschman CS: Acute-phase responses and SIRS/MODS: The good, the bad, and the
nebulous. Crit Care Med 26:1630–1631, 1998.
Gando S: Disseminated intravascular coagulation in trauma patients. Semin Thromb
Hemostasis 27:585–592, 2001. Rubin 5e Suggested Readings P. 21 of 97
Jacobi J: Pathophysiology of sepsis. Am J Health Syst Pharm 59:S3–8, 2002.
Kearon C: Natural history of venous thromboembolism. Circulation 107:122–130, 2003.
Knuefermann P, Nemoto S, Baumgarten G, et al.: Cardiac inflammation and innate
immunity in septic shock: Is there a role for toll-like receptors? Chest 121:1329–1336,
2002.
Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock. Crit Care Clin
16: 251–287, 2000.
Okajima K: Regulation of inflammatory responses by natural anticoagulants. Immunol
Rev 184:258–274, 2001.
Opal SM, Huber CE: Bench-to-bedside review: Toll-like receptors and their role in septic
shock. Crit Care 6:125–136, 2002.
Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 3328:1471–1477,
1993.
Strassburg CP: Shock liver. Best Practice Res Clin Gastroenterol 17:369–381, 2003.
Tjardes T, Neugebauer E: Sepsis research in the next millennium: Concentrate on the
software rather than the hardware. Shock 17:1–8, 2002.
Tracey KJ, Cerami A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic
target. Annu Rev Med 45:491–503, 1994.
Van Amersfoort ES, Van Berkel TJ, Kuiper J: Receptors, mediators, and mechanisms
involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16:379–414, 2003.
Chapter 8 Rubin 5e Suggested Readings P. 22 of 97
Amdur MO, Doull J, Klaassen CD: Casarett and Doull’s Toxicology, 4th ed. New York:
Pergamon Press, 1991.
Craighead JE: Pathology of environmental and occupational disease. St. Louis: Mosby,
1995.
Di Maio VJM, Di Maio D, Di Maio DJ: Forensic pathology, 2nd ed. Boca Raton, FL:
CRC Press, 2001.
The relative biological effectiveness of radiations of different quality. Report No. 104.
Bethesda, MD: National Council on Radiation Protection and Measurements, 1990.
Strickland GT: Hunter’s Tropical Medicine, 6th ed. Philadelphia: WB Saunders, 1984.
Sullivan JB, Krieger GR: Clinical environmental health and toxic exposures.
Philadelphia: Lippincott Williams & Wilkins, 2001.
Tedeschi CG, Eckert WG, Tedeschi LG: Forensic medicine: A study in trauma and
environmental hazards. Philadelphia: WB Saunders, 1977.
Review Articles
Ames BB, Gold LS: The causes and prevention of cancer: The role of the environmnt.
Biotherapy 11:205–220, 1998.
Baghurst PA, McMichael AJ, Wigg NR: Environmental exposure to lead and children’s
intelligence at age of seven years. The Port Pirie cohort study. N Engl J Med 327:1279–
1284, 1992.
Bamoya J, Glantz SA: Cardiovascular effects of secondhand smoke. Circulation
111:2684–2698, 2005.
Bolger PM, Schwertz BA: Mercury and health. N Engl J Med 347:1735–1736, 2002. Rubin 5e Suggested Readings P. 23 of 97
Brook RD, Franklin B, Cascio W, et al.: Air pollution and cardiovascular disease: A statement for healthcare professionals from the Expert Panel on Population and
Prevention Science of the American Heart Association. Circulation 109:2655–2671,
2004.
Cohen BL: Cancer risk from low-level radiation. Am J Roentgenol 179:1137–1143, 2002.
Curet LB, Hsi AC: Drug abuse during pregnancy. Clin Obst Gynecol 45:73–88, 2002.
Darby S, Hill D, Auvinen A, et al.: Radon in homes and risk of lung cancer:
Collaborative analysis of individual data from 13 European case-control studies. BMJ
330:223, 2005.
Goldfrank LR, Hoffman RS: The cardiovascular effects of cocaine: Update 1992. In:
Acute cocaine intoxication: Current methods of treatment. NIDA Research Monograph
No. 123. Rockville, MD: National Institute of Drug Abuse, 1993.
Hacksaw AK, Law MR, Wald NJ: The accumulated evidence on lung cancer and environmental tobacco smoking. BMJ 315:980–988, 1997.
Hsu PC, Guo YL: Antioxidant nutrients and lead toxicity. Toxicology 180:33–44, 2002.
Karch SB: Introduction to the forensic pathology of cocaine. Am J Forens Med Pathol
12:126–131, 1991.
Kjaerheim K, Gaard M, Andersen A: The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancers: A prospective study of 10,900 Norwegian men. Cancer
Caus Cont 9:99–108, 1998.
Krotkiewski M: Thyroid hormones in the pathogenesis and treatment of obesity. Eur J
Pharmacol 440:85–98, 2002. Rubin 5e Suggested Readings P. 24 of 97
La Vecchia C, Bosetti C: Benefits and risks of oral contraceptives on cancer. Eur J
Cancer Prev 13:467–470, 2004.
Lee S, Kolonel L, Wilkens L, et al.: Postmenopausal hormone therapy and breast cancer risk: The multiethnic cohort. Int J Cancer 118:1285–1291, 2006.
Lynge E, Anttila A, Hemminki K: Organic solvents and cancer. Cancer Causes Control
8:406–419, 1997.
McBride PE: The health consequences of smoking: Cardiovascular disease. Med Clin
North Am 76:333–353, 1992.
McCunney RJ: Asthma, genes, and air pollution. J Occup Environ Med 47:1285–1291,
2005.
Moysich KB, Menezes RJ, Michalek AM: Chernobyl-related ionizing radiation exposure and cancer risk: An epidemiological review. Lancet Oncol 3:269–279, 2002.
Muccioli G, Tschöp M, Papotti M, et al.: Neuroendocrine and peripheral activities of ghrelin: Implication in metabolism and obesity. Eur J Pharmacol 440:235–254, 2002.
Neuberger JS, Gesell TF: Residential radon exposure and lung cancer: Risk in nonsmokers. Health Physics 83:1–18, 2002.
Newcomb PA, Carbone PP: The health consequences of smoking. Med Clin North Am
76:305–331, 1992.
Olney JW, Wozniak DF, Jevtovic-Todorovic V, et al.: Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 12:488–498, 2002.
Raitiola HS, Pukander JS: Etiological factors of laryngeal cancer. Acta Otol-Laryng
529:S215–S217, 1997.
Ravussin E: Chemical sensors of feast and famine. J Clin Invest 109:1537–1540, 2002. Rubin 5e Suggested Readings P. 25 of 97
Romero A, Alonso C, Rincon M, et al.: Risk of venous thromboembolic disease in women. A qualitative systematic review. Eur J Obst Gynecol 121:8–17, 2005.
Schlecht NF, Franco EL, Pintos J, et al.: Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology 10:412–418,
1999.
Shields PG: Molecular epidemiology of smoking and lung cancer. Oncogene 21:6870–
6876, 2002.
Thackray H, Tifft C: Fetal alcohol syndrome. Pediatr Int Rev 22:47–55, 2001.
Tominaga S: Major avoidable risk factors of cancer. Cancer Lett 143:S19–S23, 1999.
Vainio H, Weiderpass E, Kleihues P: Smoking cessation in cancer prevention. Toxicology
166:47–52, 2001.
Webster EW: Garland lecture: On the question of cancer induction by small x-ray doses.
Am J Roentgenol 137:647– 666, 1981.
Zatonski W, Becher H, Lissowska J, et al.: Tobacco, alcohol, and diet in the etiology of laryngeal cancer: A population-based case-control study. Canc Caus Cont 2:3–10, 1991.
Chapter 9
Books
Baron S: Medical microbiology, 4th ed. New York: Churchill-Livingstone, 1996.
Connor DH, Chandler FW, Schwartz DA, et al.: Pathology of infectious diseases, vol I and II. Stamford, CT: Appleton & Lange, 1997.
Cook M: Manson’s tropical disease, 20th ed. Philadelphia: WB Saunders, 1995. Rubin 5e Suggested Readings P. 26 of 97
Gorbach SL, Bartlett JG, Blacklow NR: Infectious diseases in medicine and surgery, 2nd
ed. Philadelphia: WB Saunders, 1997.
Gutierrez Y: Diagnostic pathology of parasitic infections with clinical correlations.
Philadelphia: Lea & Febiger, 1990.
Heath PT, McVernon J: The UK Hib vaccine experience. Arch Dis Child 86:396–399,
2002.
Holmes KK, Mardh P, Sparling PF, et al.: Sexually transmitted diseases, 3rd ed. New
York: McGraw-Hill, 1997.
Mandell GL, Bennett JE, Dolin E: Principles and practice of infectious diseases, 3rd ed.
New York: Churchill-Livingstone, 1995.
Murray PR: Manual of clinical microbiology, 6th ed. Washington, DC: ASM Press, 1995.
Remington JS, Klein JO: Infectious diseases of the fetus and newborn infant, 4th ed.
Philadelphia: WB Saunders, 1994.
Rippon JW: Medical mycology: The pathogenic fungi and the pathogenic actinomycetes,
3rd ed. Philadelphia: WB Saunders, 1988.
Rom WN, Garay SM: Tuberculosis. Boston: Little, Brown, 1996.
Reviews
Genta RM: Diarrhea in helminthic infections. Clin Infect Dis 19:S122–S129, 1993.
Meslin FX: Surveillance and control of emerging zoonoses. World Health Stat Q 45:200–
207, 1992.
Steere AC: Lyme disease. N Engl J Med 321:586–596, 1989. Rubin 5e Suggested Readings P. 27 of 97
Walker DH, Barbour AG, Olivier JH, et al.: Emerging bacterial zoonotic and vector-
borne diseases. Ecological and epidemiological factors. JAMA 275:463–469, 1996.
Walker DH, Yamolska O, Grinberg LM: Death at Sverdlovsk: What have we learned?
Am J Pathol 144:1135–1141, 1994.
Chapter 10
Books
Gotlieb AI, Silver MD: Atherosclerosis: Pathogenesis and pathology. In: Silver MD,
Gotlieb AI, Schoen FJ (eds): Cardiovascular pathology. New York: Churchill-
Livingstone, 2001:68–106.
McManus BM, Braunwald E: Atlas of cardiovascular pathology. Philadelphia: Current
Medicine, 2000.
Review Articles
Carlson JA, Ng BT, Chen K-R: Cutaneous vasculitis update: Diagnostic criteria,
classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J
Dermatopathol 27:504–528, 2005.
Cunningham KS, Gotlieb AI: The role of shear stress in the pathogenesis of
atherosclerosis. Lab Invest 85:9–23, 2005.
Davies MJ, Bland JM, Hangartner JR, et al.: Factors influencing the presence or absence
of acute coronary artery thrombi in sudden ischemic death. Eur Heart J 10:203–208,
1989. Rubin 5e Suggested Readings P. 28 of 97
Gotlieb AI: Atherosclerosis and acute coronary syndromes. Cardiovasc Pathol 14:181–
184, 2005.
Hansson GK: Mechanisms of disease. Inflammation, atherosclerosis, and coroanry artery disease. N Engl J Med 352:1685–1695, 2005.
Jennette JC, Falk RJ: Do vasculitis categorization systems really matter? Curr Rheumatol
Rep 2:430–438, 2000.
Jennette JC, Falk RJ, Andrassy K, et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192, 1994.
Lee JSY, Gotlieb AI: Understanding the role of the cytoskeleton in the complex regulation of the endothelial repair. Histol Histopathol 18:879–887, 2003.
Nicholson AC, Hajjar DP: Herpesviruses in atherosclerosis and thrombosis: Etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 18:339–348, 1998.
Rao DS, Goldin JG, Fishbein MC: Determinants of plaque instability in atherosclerotic vascular disease. Cardiovasc Pathol 14:285–293, 2005.
Schoen FJ, Libby P: Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med
1:216–223, 1991.
Stary HC, Blankenhorn DH, Chandler AB, et al.: A definition of the intima of human arteries and of its atherosclerosis-prone regions: A report from the Committee on
Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
Circulation 85:391–405, 1992.
Stary HC, Chandler AB, Dinsmore RE, et al.: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from Rubin 5e Suggested Readings P. 29 of 97
the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart
Association. Arterioscler Thromb Vas Biol 15:1512–1531, 1995.
Stary HC, Chandler AB, Glagov S, et al.: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb
14:840–856, 1994.
Virmani R, Burke AP, Farb A: Sudden cardiac death. Cardiovasc Pathol 10:275–282,
2001.
Waller BF, Orr CM, Pinkerton CA, et al.: Morphologic observations late after coronary balloon angioplasty: Mechanisms of acute injury and relationship to restenosis.
Radiology 174:961–967, 1990.
Chapter 11
Books
Braunwald E: Essential atlas of heart disease, 2nd ed. Philadelphia: Current Medicine,
2001.
Braunwald E, Zipes DP, Libby P, et al.: (eds): Heart disease: A textbook of
cardiovascular medicine, 7th ed. Philadelphia: WB Saunders, 2004.
Lilly LS: Pathophysiology of heart disease, 3rd ed. Philadelphia: Lippincott Williams &
Wilkins, 2003.
Perloff JK, Child JS: Congenital heart disease in adults, 2nd ed. Philadelphia: WB
Saunders, 1998. Rubin 5e Suggested Readings P. 30 of 97
Schoen FJ: Interventional and surgical cardiovascular pathology. Philadelphia: WB
Saunders, 1989.
Silver MD, Gotlieb AI, Schoen FJ: Cardiovascular pathology, 3rd ed. New York:
Churchill-Livingstone, 2001.
Review Articles
Aretz HT, Billingham ME, Edwards WD, et al.: Myocarditis. Am J Cardiovasc Pathol
1:3–14, 1987.
Backs J, Olson EN: Control of cardiac growth by histone acetylation/deacetylation. Circ
Res 98:15–24, 2006.
Dare AJ, Veinot JP, Edwards WD, et al.: New observations on the etiology of aortic valve disease. Hum Pathol 24:1330– 1338, 1993.
Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J
Med 341:1276–1283, 1999.
Kang PM, Izumo S: Apoptosis in heart: basic mechanisms and implications in
cardiovascular diseases. Trends Cardiovasc Med 9:177–182, 2003.
Kim KS, Hufnagel G, Chapman NM, et al.: The group B coxsackieviruses and myocarditis. Rev Med Virol 6:355–368, 2001.
Kloner RA, Bolli R, Marban E, et al.: Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop. Circulation 18:1848–1867,
1998.
Leri A, Kajstura J, Anversa P: Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85:1373–1416, 2005. Rubin 5e Suggested Readings P. 31 of 97
Marian AJ: Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic
cardiomyopathy. Lancet 355:58–60, 2000.
Mylonakis E, Calderwood SB: Infective endocarditis in adults. N Engl J Med 18:1318–
1330, 2001.
Prall OW, Elliott DA, Harvey RP: Developmental paradigms in heart disease: Insights from tinman. Ann Med 34:148–156, 2002.
Roberts R, Sigwart U: New concepts in hypertrophic cardiomyopathies, Part I.
Circulation 104:2113–2116, 2001.
Roberts R, Sigwart U: New concepts in hypertrophic cardiomyopathies, Part II.
Circulation 104:2249–2252, 2001.
Saffitz JE: The pathology of sudden cardiac death in patients with ischemic heart disease:
Arrhythmology for anatomic pathologists. Cardiovasc Pathol 14:195–203, 2005.
Seidman JG, Seidman C: The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 104:557–567, 2001.
Towbin JA: The role of cytoskeletal proteins in cardiomyopathies. Current Opin Cell
Biol 10:131–139, 1998.
Virmani R, Burke AP, Farb A: Sudden cardiac death. Cardiovasc Pathol 10:211–218,
2001.
Chapter 12
Books
Churg A, Green FHY: Pathology of occupational lung disease. Baltimore: Williams &
Wilkins, 1998. Rubin 5e Suggested Readings P. 32 of 97
Colby TV: Atlas of pulmonary surgical pathology. Philadelphia: WB Saunders, 1991.
Colby TV, Koss MN, Travis WD: Tumors of the lower respiratory tract. Armed Forces
Institute of Pathology Fascicle, third series. Washington, DC: Armed Forces Institute of
Pathology, 1995.
Dail DH, Hammar SP: Pulmonary pathology. New York: Springer-Verlag, 1994.
Fishman AP, Elias JA: Pulmonary diseases and disorders. New York: McGraw-Hill,
Health Professions Division, 1998.
Katzenstein AL: Surgical pathology of non-neoplastic lung disease. Philadelphia: WB
Saunders, 1997.
Murray JF, Nadel JA, Mason RJ, et al.: Textbook of respiratory medicine. Philadelphia:
WB Saunders, 2000.
Roggli VL, Greenberg SD, Pratt PC: Pathology of asbestos-associated diseases. Boston:
Little, Brown, 1992.
Schwartz MI, King TE: Interstitial lung disease. Hamilton, BC: Decker, 1998.
Spencer H, Hasleton PS: Spencer’s pathology of the lung. New York: McGraw-Hill,
Health Professions Division, 1996.
Thurlbeck WM, Churg A: Pathology of the lung. New York: Thieme, 1995.
Travis WD, Brambilla E, Müller-Hermelink HK, et al.: Pathology and genetics: Tumours of the lung, pleura, thymus and heart, Lyon, France: IARC, 2004.
Travis WD, Colby TV, Koss MN, et al.: Non-neoplastic disorders of the lower respiratory tract. Washington, DC: American Registry of Pathology, 2002.
Review Articles Rubin 5e Suggested Readings P. 33 of 97
Joint Statement of the American Thoracic Society (ATS), the European Respiratory
Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous
Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive
Committee, February 1999. Statement on sarcoidosis. Am J Respir Crit Care Med
160:736–755, 1999.
Agostini C, Semenzato G: Immunology of idiopathic pulmonary fibrosis. Curr Opin
Pulm Med 2:364–369, 1996.
Bjoraker JA, Ryu JH, Edwin MK, et al.: Prognostic significance of histopathologic
subsets in idiopathic pulmonary fibrosis. J Respir Crit Care Med 157:199–203, 1998.
Busse WW, Lemanske RF: Review articles: Advances in immunology: Asthma. N Engl J
Med 344:350–362, 2001.
Epler GR: Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 161:158–164,
2001.
Evans MD, Pryor WA: Cigarette smoking, emphysema, and damage to alpha 1-
proteinase inhibitor. Am J Physiol 266:493–611, 1994.
Guthrie R: Community-acquired lower respiratory tract infections: Etiology and
treatment. Chest 120:2021–2034, 2001.
King TE Jr, Costabel U, Cordier J-F, et al.: Idiopathic pulmonary fibrosis: Diagnosis and
treatment. Am J Respir Crit Care Med 161:646–664, 2000.
Knight KR, Burdeon JG, Cook L, et al.: The proteinase-antiproteinase theory of
emphysema: A speculative analysis of recent advances into the pathogenesis of
emphysema. Respirology 2:91–95, 1997. Rubin 5e Suggested Readings P. 34 of 97
Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: Clinical relevance of
pathologic classification. Am J Respir Crit Care Med 157:1301–1315, 1998.
Lynch JP 3rd, Kazerooni EA, Gay SE: Pulmonary sarcoidosis. Clin Chest Med 18:755–
785, 1997.
Martinez FJ: Diagnosing chronic obstructive pulmonary disease. The importance of
differentiating asthma, emphysema, and chronic bronchitis. Postgrad Med 103:112–125,
1998.
Nicotra MB: Bronchiectasis. Semin Respir Infect 9:31–40, 1994.
Otto WR: Lung stem cells. Int J Exp Pathol 78:291–310, 1997.
Peak JK: The epidemiology of asthma. Curr Opin Pulm Med 2:7–15, 1996.
Ross JA, Rosen GD: The molecular biology of lung cancer. Curr Opin Pulm Med 8:265–
269, 2002.
Salvaggio JE: Extrinsic allergic alveolitis (hypersensitivity pneumonitis): Past, present,
and future. Clin Exp Allergy 27:18–25, 1997.
Schulger NW, Rom WN: The host immune response to tuberculosis. Am J Respir Crit
Care Med 157:679–691, 1998.
Travis WD, Garg K, Franklin WA, et al.: Evolving concepts in the pathology and
computed tomography imaging of lung adenocarcinoma and bronchioloalveolar
carcinoma. J Clin Oncol 23:3279–3287, 2005.
Travis WD, King TE, Bateman ED, et al.: ATS/ERS International Multidisciplinary
Consensus classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med
165:277–304, 2002.
Rubin 5e Suggested Readings P. 35 of 97
Chapter 13
Books
Chandrasoma P: Gastrointestinal pathology, 1st ed. Stamford, CT: Appleton & Lange,
1999.
Morson BC, Dawson IMP, Day DW, et al.: Morson and Dawson’s gastrointestinal pathology, 4th ed. Oxford, UK: Blackwell Scientific, 2003.
Odze RD, Goldblum JR, Crawford JM: Surgical pathology of the GI tract, liver, biliary tract, and pancreas, 1st ed. Philadelphia: Saunders, 2004.
Sleisenger MH, Feldman F, Friedman LS: Gastrointestinal disease, 7th ed. Philadelphia:
WB Saunders, 2002.
Yamada T: Textbook of gastroenterology, 3rd ed. Philadelphia: JB Lippincott, 2003.
Review Articles
Ahmad T, Armuzzi A, Bunce M, et al.: The molecular classification of the clinical manifestations of Crohn’s disease. Gastroenterology 122:854–866, 2002.
Bocker-Edmonston T, Cuesta KH, Burkholder S, et al.: Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum Pathol 31:1506–1514, 2000.
Bond JH, for the practice parameters committee of the American College of
Gastroenterology: Polyp guideline: Diagnosis, treatment, and surveillance for patients with colorectal polyps. Am J Gastroenterol 95:3053–3063, 2000.
Brandtzaeg P, Haraldsen G, Rugtveit J: Immunopathology of human inflammatory bowel disease. Semin Immunopathol 18:555–589, 1997. Rubin 5e Suggested Readings P. 36 of 97
Cagir B, Gelman A, Park J, et al.: Guanylyl cyclase C messenger RNA is a biomarker for
recurrent stage II colorectal cancer. Ann Intern Med 131:805–812, 1999.
Carter PS: Anal cancer: Current perspectives. Dig Dis 11:239–251, 1993.
Cave DR: Transmission and epidemiology of Helicobacter pylori. Am J Med 100:12S–
17S, 1996.
Czinn SJ, Nedrud JG: Immunopathology of Helicobacter pylori infection and disease.
Semin Immunopathol 18:495–514, 1997.
Dieterich W, Ehnis T, Bauer M: Identification of tissue transglutaminase as the
autoantigen of celiac disease. Nat Med 3:P797–801, 1997
Dixon MF, Genta RM, Yardley JH, et al.: Classification and grading of gastritis: The
updated Sydney System. International Workshop on the Histopathology of Gastritis.
Houston, 1994. Am J Surg Pathol 20:1161–1181, 1996.
Eaden JA, Mayberry JF: Colorectal cancer complicating ulcerative colitis: A review. Am
J Gastrointest 95:2710–2719, 2000.
Falk GW: Barrett’s esophagus. Gastroenterology 122:1569–1591, 2002.
Farrell RJ, Kelly CP: Diagnosis of celiac sprue. Am J Gastroenterol 96:3237–3246, 2001
Fiocchi C: Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology
115:182–205, 1998.
Fletcher CDM, Berman JJ, Corless C, et al.: Diagnosis of gastrointestinal stromal tumors:
A consensus approach. Hum Pathol 33:459–465, 2002.
Fodde R, Smits R, Clevers H: APC, signal transduction and genetic instability in
colorectal cancer. Nat Rev 1:55–67, 2001. Rubin 5e Suggested Readings P. 37 of 97
Foulkes WD: A tale of four syndromes: Familial adenomatous polyposis, Gardner
syndrome, attenuated APC and Turcot syndrome. Q J Med 88:853–863, 1995.
Giardiello FM, Lazenby AJ, Bayless TM: The new colitides, collagenous, lymphocytic
and diversion colitis. Gastroenterol Clin North Am 24:717–729, 1995.
Gretz JE, Achem SR: The watermelon stomach: Clinical presentation, diagnosis and
treatment. Am J Gastrointest 93:890–895, 1998.
Gryfe R, Kim H, Hsieh ETK: Tumor microsatellite instability and clinical outcome in
young patients with colorectal cancer. N Engl J Med 342:69–77, 2000.
Howden CW: Clinical expressions of Helicobacter pylori infection. Am J Med 100:27S–
32S, 1996.
Huntsman DG, Carneiro F, Lewis FR: Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344:1904–1909, 2001.
Jass JR: Serrated route to colorectal cancer: Back street or super highway? J Pathol
193:283–285, 2001.
Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87:159–170,
1996.
Kozol RA, Dekhne N: Helicobacter pylori and the pathogenesis of duodenal ulcer. J Lab
Clin Med 124:623–626, 1994.
Kulke MH, Mayer RJ: Carcinoid tumors. N Engl J Med 340:858–868, 1999.
Mittal RK, Balaban DH: The esophagogastric junction. N Engl J Med 336:924–932,
1997.
Quellette AJ, Selsted ME: Paneth cell defensins: Endogenous peptide components of intestinal host defense. FASEB J 10:1280–1289, 1996. Rubin 5e Suggested Readings P. 38 of 97
Pardi DS, Smyrk TC, Tremaine WJ, et al.: Microscopic colitis: A review. Am J
Gastrointest 97:794–802, 2002.
Peek RM, Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat
Rev 2:28–37, 2002.
Podolsky D: Inflammatory bowel disease. N Engl J Med 347:417–429, 2002.
Raoult D, Birg ML, La Scola B, et al.: Cultivation of the bacillus of Whipple’s disease. N
Engl J Med 342:620–625, 2000.
Sampliner RE, and the practice parameters committee of the American College of
Gastroenterology: Updated guidelines for the diagnosis, surveillance, and therapy of
Barrett’s esophagus. Am J Gastroenterol 97:1888–1895, 2002.
Savarino SJ: Diarrhoeal disease: Current concepts and future challenges: Enteroadherent
Escherichia coli: A heterogeneous group of E. coli implicated as diarrhoeal pathogens.
Trans R Soc Trop Med Hyg 87:49–53, 1993.
Schatzkin A, Lanza E, Corle D, et al.: Lack of effect of a low-fat, high-fiber diet on the
recurrence of colorectal adenomas. N Engl J Med 3421149–1155, 2000.
Schlemper RJ, Riddell RH, Kato Y, et al.: The Viena classification of gastrointestinal
epithelial neoplasia. Gut 47:251–255, 2000.
Schneider T, Ullrich R, Zeitz M: Immunopathology of human immunodeficiency virus
infection in the gastrointestinal tract. Semin Immunopathol 18:515–534, 1997.
Schuppan D: Current concepts of celiac disease pathogenesis. Gastroenterology
119:234–242, 2000.
Scott H, Nilsen E, Sollid LM, et al.: Immunopathology of gluten-sensitive enteropathy.
Semin Immunopathol 18:535–554, 1997. Rubin 5e Suggested Readings P. 39 of 97
Spechler SJ: Barrett’s esophagus. N Engl J Med 346:836–842, 2002.
Spigelman AD, Arese P, Phillips RK: Polyposis: The Peutz-Jeghers syndrome. Br J Surg
82:1311–1314, 1995.
Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 347:1175–1186,
2002.
Voutilainen M, Farkkila M, Mecklin JP, et al.: and the Central Finland Endoscopy Study
Group. Am J Gastroenterol 94:3175–3180, 1999.
Voutilainen M, Farkkila M, Pekka Mecklin J, et al.: Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to
Helicobacter pylori infection and gastroesophageal reflux disease. Am J Gastroenterol
94:3175–3180, 1999.
Wheeler JMD: DNA mismatch repair genes and colorectal cancer. Gut 47:148–153,
2000.
Chapter 14
Books
Bircher J, Benhamou J-P, McIntyre N, et al.: Oxford Textbook of Clinical Hepatology,
2nd ed. Oxford, UK: Oxford University Press, 1999.
Farrel GC: Drug-induced liver disease. Edinburgh: Churchill-Livingstone, 1994.
Ishak KG, Goodman ZD, Stocker J: Tumors of the liver and intrahepatic bile ducts. In:
Atlas of tumor pathology, series 3, fascicle 31. Washington, DC: Armed Forces Institute of Pathology, 2001. Rubin 5e Suggested Readings P. 40 of 97
MacSween RNM, Burt AD, Portmann BC, et al.: Pathology of the liver, 4th ed.
Edinburgh: Churchill-Livingstone, 2002.
Schiff L, Schiff ER: Diseases of the liver, 7th ed. Philadelphia: JB Lippincott, 1999.
Sherlock S, Dooley J: Diseases of the liver and biliary system, 11th ed. Oxford, UK:
Blackwell Scientific, 2002.
Zimmerman, HJ: Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1999.
Review Articles
Al-Khalidi JA, Czaja A: Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis. Mayo Clin Proc 76:1237–1252, 2001.
Bacon BR: Hemochromatosis: Diagnosis and management. Gastroenterology 120:718–
725, 2001.
Brechot C: Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127:S56–S61, 2004
Cuthbert JA: Hepatitis A: Old and new. Clin Microbiol Rev 14:38–58, 2001.
Desmet VJ, Roskams T: Cirrhosis reversal: A duel between dogman and myth. J Hepatol
40:860–867, 2004.
Dowling RH: Pathogenesis of gallstones. Aliment Pharmacol Ther 14:39–47, 2000.
Fausto N: Liver regenearation and repair: Hepatocytes, progenitor cells, and stem cells.
Hepatology 39:1477–1487, 2004.
Feitelson MA: Hepatocellular injury in hepatitis B and C virus infections. Clin Lab Med
16:307–324, 1996. Rubin 5e Suggested Readings P. 41 of 97
French SW: Mechanisms of alcoholic liver injury. Can J Gastroenterol 14:327–332,
2000.
Gish RG, Mason A: Autoimmune liver disease. Current standards, future directions. Clin
Liver Dis 5:287–314, 2001.
Gochee PA, Powell LW: What’s new in hemochromatosis? Curr Opin Hematol 8:98–
104, 2001.
Hazell AS, Butterworth RF: Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 222:99–112, 1999.
Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med 353:1261–1273,
2005
Ko CW, Lee SP: Gallstone formation. Gastroenterol Clin North Am 28:99–115, 1999.
Drawitt EL: Autoimmune hepatitis. N Engl J Med 354:54–66, 2006
Langner C, Denk H: Wilson disease. Virchows Arch 445:111–118, 2004
Lauer GM, Walker BD: Hepatitis C infection. N Engl J Med 345:41–51, 2001.
Loudianos G, Gitlin J: Wilson’s disease. Semin Liver Dis 20:353–364, 2000.
Lyon E, Frank E: Hereditary hemochromatosis since discovery of the HFE gene. Clin
Chem 47:1147–1156, 2001.
Macdonald GA: Pathogenesis of hepatocellular carcinoma. Clin Liver Dis 5:69–85, 2001.
MacFaul GR, Chapman RW: Sclerosing cholangitis. Curr Opin Gastroenterol 21:348–
353, 2005.
Narayanan MKV, Shah V, Kamath, PS: The Budd-Chiari syndrome. N Engl J Med
350:578–585, 2004. Rubin 5e Suggested Readings P. 42 of 97
Olnes MJ, Rodrigo E: A review and update on cholangiocarcinoma. Oncology 66:167–
179, 2004.
Pauli-Magnus C, Meier PJ: Hepatocellular transporters and cholestasis. J Clin
Gastroenterol 39:S103–S110, 2005.
Pietrangelo A: Hereditary hemochromatosis: A new look at an old disease. N Engl J Med
350:2383–2397, 2004.
Portmann B, Koukoulis G: Pathology of the liver allograft. Curr Top Pathol 92:61–105,
1999.
Riordan SM, Williams R: The Wilson’s disease gene and phenotypic diversity. J Hepatol
34:165–171, 2001.
Sherlock S: Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune
cholangitis. Clin Liver Dis 4:97–113, 2000.
Tanaka A, Borchers AT, Ishibashi H, et al.: Genetic and familial considerations of
primary biliary cirrhosis. Am J Gastroenterol 96:8–15, 2001.
Taub R: Liver regenearation: From myth to mechanism. Nature Rev Mol Cell Biol 5:836–
847, 2004.
Thompson R, Jansen PLM: Genetic defects in hepatocanalicular transport. Semin Liver
Dis 20:365–372, 2000.
Torok N, Gores GJ: Cholangiocarcinoma. Semin Gastrointest Dis 12:125–132, 2001.
Trauner M, Fickert P, Zollner G: Genetic disorders and molecular mechanisms in
cholestatic liver disease: A clinical approach. Semin Gastrointest Dis 12:66–88, 2001.
Tsukamoto H, Lu SC: Current concepts in the pathogenesis of alcoholic liver injury.
FASEB J 15:1335–1349, 2001. Rubin 5e Suggested Readings P. 43 of 97
Wright TL, Monto A: The epidemiology and prevention of hepatocellular carcinoma.
Semin Oncol 28:441–449, 2001.
Zein CO, Lindor KD: Primary sclerosing cholangitis. Semin Gastrointest Dis 12:103–
112, 2001.
Chapter 15
Books
Cruickshank AH, Benbow EW: Pathology of the pancreas. New York: Springer, 1995.
Owen DA, Kelly JK: Pathology of the gallbladder, biliary tract, and pancreas.
Philadelphia: WB Saunders, 2001.
Solcia E, Capella C, Kloppel G: Tumors of the pancreas. In: Atlas of tumor pathology, series 3, fascicle 20. Washington, DC: Armed Forces Institute of Pathology, 1997.
Review Articles
Baron R, Morgan DE: Acute necrotizing pancreatitis. N Engl J Med 340:1412–1417,
1999.
Brugge WR, Lauwers GY, Sahani D, et al.: Cystic neoplasms of the pancreas. N Engl J
Med 351:1218–1226, 2004.
Chen J-M, Ferec C: Molecular basis of hereditary pancreatitis. Eur J Hum Genet 8:473–
479, 2000.
Choudari CP, Lehman GA, Sherman S: Pancreatitis and cystic fibrosis gene mutations.
Gastroenterol Clin North Am 28:543–549, 1999. Rubin 5e Suggested Readings P. 44 of 97
Cooperman AM: An overview of pancreatic pseudocysts. Surg Clin North Am 81:391–
397, 2001.
Deshpande V, Mino-Kenudson M, Brugge W, et al.: Autoimmune pancreatitis. More than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med
129:1148–1154, 2005.
Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR: Pancreatic cancer genetics.
Pancreatology 1:571–575, 2001.
Etemad B, Whitcomb DC: Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 120:682–707, 2001.
Gasslander T, Arnelo U, Albiin N, et al.: Cystic tumors of the pancreas. Dig Dis 19:57–
62, 2001.
Inoue S, Tezel E, Nakao A: Molecular diagnosis of pancreatic cancer.
Hepatogastroenterology 48:933–938, 2001.
Levy MJ, Geenen JE: Idiopathic acute recurrent pancreatitis. Am J Gastroenterol
96:2540–2555, 2001.
Wick MR, Graeme-Cook FM: Pancreatic neuroendocrine neoplasms: A current summary of diagnostic, prognostic, and differential diagnostic information. Am J Clin Pathol
115:S28–45, 2001.
Chapter 16
Books
D’Agati V, Jennette JC, Silva FG: Non-neoplastic renal disease. Washington, DC:
American Registry of Pathology, 2005. Rubin 5e Suggested Readings P. 45 of 97
Jennette JC, Olson JL, Schwartz MM, et al.: Heptinstall’s pathology of the kidney, 6th ed.
Philadelphia: Lippincott Williams & Wilkins, 2006.
Murphy WM: Urological pathology, 2nd ed. Philadelphia: WB Saunders, 1997.
Murphy WM, Beckwith JB, Farrow GM: Tumors of the kidney, bladder and related urinary structures. Washington, DC: Armed Forces Institute of Pathology, 1994.
Review Articles
Colvin RB: The renal allograft biopsy. Kidney Int 50:1069–1082, 1996.
D’Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223–
1241, 1994.
Freedman BI, Iskandar SS, Appel RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 25:207–221, 1995.
Glassock RJ, Cohen AH: The primary glomerulopathies. Disease-A-Month 42:329–383,
1996.
Harris PC, Ward CJ, Peral B, et al.: Polycystic kidney disease 1: Identification and analysis of the primary defect. J Am Soc Nephrol 6:1125–1133, 1995.
Jennette JC: Rapidly progressive and crescentic glomerulonephritis. Kidney Int 63:1164–
1172, 2003.
Jennette JC, Falk RJ: Diagnosis and management of glomerular diseases. Med Clin North
Am 81:653–677, 1997.
Jennette JC, Falk RJ: Small vessel vasculitis. N Engl J Med 337:1512–1523, 1997.
Madaio MP, Harrington JT: The diagnosis of glomerular diseases: Acute glomerulonephritis and the nephrotic syndrome. Arch Intern Med 161:25–34, 2001. Rubin 5e Suggested Readings P. 46 of 97
Mauiyyedi S, Crespo M, Collins AB, et al.: Acute humoral rejection in kidney
transplantation: II. Morphology, immunopathology, and pathological classification. J Am
Soc Nephrol 13:779–787, 2002.
Pantuck AJ, Zisman A, Belldegrun A: Biology of renal cell carcinoma: Changing
concepts in classification and staging. Semin Urol Oncol 19:72–79, 2001.
Reddy JC, Licht JD: The WT1 Wilms tumor suppressor gene. How much do we really
know? Biochim Biophys Acta 1287:1–28, 1996.
Silva FG, Hogg RJ: Glomerular lesions associated with the acute nephritic syndrome and
hematuria. Semin Diagn Pathol 5:4–38, 1988.
Chapter 17
Books
Eble JN, Sauter G, Epstein JE, et al.: Pathology & genetics. Tumours of the urinary
system and male genital organs. World Health Organization Classification of Tumors.
Lyon, France: IARC Press, 2004.
Epstein JI, Yang XJ: Prostate biopsy interpretation, 3rd ed. Philadelphia: Lippincott
Williams & Wilkins, 2002.
Foster CS, Ross JS: Pathology of the urinary bladder. Philadelphia: Saunders, 2004.
Teichman JMH: 20 Common problems in urology. New York: McGraw-Hill, 2001.
Ulbright TM, Amin MB, Young RH: Atlas of tumor pathology: Tumors of the testis,
adnexa, spermatic cord and scrotum. Washington, DC: Armed Forces Institute of
Pathology, 1999.
Rubin 5e Suggested Readings P. 47 of 97
Review Articles
Bostwick DG, Mikuz G: Urothelial papillary (exophytic) neoplasms. Virchows Arch
441:109, 2002.
Bostwick DG, Ramnani D, Cheng L: Diagnosis and grading of the bladder cancer and associated lesions. Urol Clin North Am 26:493, 1999.
Buechner SA: Common skin disorders of the penis. Br J Urol Int 90:498, 2002.
Concato J, Wells CK, Horwitz RI, et al.: The effectiveness of screening for prostate cancer: A nested case-control study. Arch Intern Med 166:38, 2006.
Emberton M, Andriole GL, de la Rosette J, et al.: Benign prostatic hyperplasia: A progressive disease of aging men. Urology 61:267, 2003.
Epstein JI, Allsbrook WC Jr, Amin MB, et al.: ISUP Grading Committee. The 2005
International Society of Urological Pathology (ISUP) Consensus Conference on Gleason
Grading of Prostatic Carcinoma. Am J Surg Pathol 29:1228, 2005.
Epstein JI, Amin MB, Reuter VR, et al.: The World Health Organization/International
Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg
Pathol 22:1435, 1998.
Frankel S, Smith GD, Donovan J, et al.: Screening for prostate cancer. Lancet 361:1122,
2003.
Hughes IA: Intersex. Br J Urol Int 90:769, 2002.
Jones RH, Vasey PA: New directions in testicular cancer: Molecular determinants of oncogenesis and treatment success. Eur J Cancer 39:147, 2003.
Krieger JN: Urinary tract infections: What’s new? J Urol 168:2351, 2002. Rubin 5e Suggested Readings P. 48 of 97
Leissner J, Koeppen C, Wolf HK: Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 169:955,
2003.
Marker PC, Donjacour AA, Dahiya R, et al.: Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165, 2003.
Oberpenning F, van Ophoven A, Hertle L: Interstitial cystitis: An update. Curr Opin Urol
12:321, 2002.
Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat
Rev Cancer 5:210, 2005.
Oottamasathien S, Crawford ED: Should routine screening for prostate-specific antigen be recommended? Arch Intern Med 163:661, 2003.
Pollack A, Cowen D, Troncoso P, et al.: Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x. Cancer
97:1630, 2003.
Ronald A: The etiology of urinary tract infection: Traditional and emerging pathogens.
Am J Med 113:14S, 2002.
Sirovich BE, Schwartz LM, Woloshin S: Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence? JAMA 289:1414, 2003.
Smith ND, Rubenstein JN, Eggener SE, et al.: The p53 tumor suppressor gene and nuclear protein: Basic science review and relevance in the management of bladder cancer. J Urol 169:1219, 2003.
Theodorescu D: Molecular pathogenesis of urothelial bladder cancer. Histol Histopathol
18:259, 2003. Rubin 5e Suggested Readings P. 49 of 97
Thorpe A, Neal D: Benign prostatic hyperplasia. Lancet 361:1359, 2003.
Toner GC, Frydenberg M: Poor prognosis germ-cell tumors: An unresolved challenge.
Semin Urol Oncol 20:251, 2002.
Chapter 18
Review and Multisystem Articles
Lagoo AS, Robboy SJ: Lymphoma of the female genital tract: Current status. Int J
Gynecol Pathol 25:1–21, 2006.
McCluggage WG: Recent advances in immunohistochemistry in gynaecological
pathology. Int J Gynecol Pathol 2006, in press.
Scully R, Young RH: A half century in gynecological pathology: Reminiscences of
Robert E. Scully on his career: An interview with Robert H. Young. Int J Gynecol Pathol
20:2–15, 2001.
Embryology
Fleming A, Vilain E: The endless quest for sex determination genes. Clin Genet 67:15–
25, 2005.
Park SY, Jameson JL: Minireview: Transcriptional regulation of gonadal development and differentiation. Endocrinology 146:1035–1042, 2005.
Viger RS, Silversides DW, Tremblay JJ: New insights into the regulation of mammalian sex determination and male sex differentiation. Vitam Horm 70:387–413, 2005.
Vulva Rubin 5e Suggested Readings P. 50 of 97
Fox H, Wells M: Recent advances in the pathology of the vulva. Histopathology 42:209–
216, 2003.
Hart WR: Vulvar intraepithelial neoplasia: Historical aspects and current status. Int J
Gynecol Pathol 20:16–30, 2001.
Logani S, Lu D, Quint WGV, et al.: Low-grade vulvar and vaginal intraepithelial neoplasia: Correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining. Mod Pathol 16:735–741, 2003.
McCluggage WG: A review and update of morphologically bland vulvovaginal
mesenchymal lesions. Intl J Gynecol Pathol 24:26, 2005.
Medeiros F, Nascimento AF, Crum CP: Early vulvar squamous neoplasia: Advances in
classification, diagnosis, and differential diagnosis. Adv Anat Pathol 12:20–26, 2005.
Vagina
Hatch EE, Herbst AL, Hoover RN, et al.: Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer
Causes Control 12:837–845, 2001.
Titus-Ernstoff L, Hatch EE, Hoover RN, et al.: Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 84:126–133, 2001.
Cervix
Alfsen GC, Kristensen GB, Skovlund E, et al.: Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: A population- Rubin 5e Suggested Readings P. 51 of 97
based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of
the cervix. Cancer 92:2471–2483, 2001.
Cantor SB, Atkinson EN, Cardenas-Turanzas M, et al.: Natural history of cervical
intraepithelial neoplasia: A meta- analysis. Acta Cytol 49:405–415, 2005.
Cuschieri KS, Cubie HA: The role of human papillomavirus testing in cervical screening.
J Clin Virol 32:S34–42, 2005.
Doorbar J: The papillomavirus life cycle. J Clin Virol 32:S7, 2005.
Lillo FB: Human papillomavirus infection and its role in the genesis of dysplastic and
neoplastic lesions of the squamous epithelia. New Microbiol 28:111, 2005.
Masumoto N, Fujii T, Ishikawa M, et al.: p16(INK4a) overexpression and human
papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol
34:778–783, 2003.
Raspagliesi F, Ditto A, Solima E, et al.: Microinvasive squamous cell cervical carcinoma.
Crit Rev Oncol Hematol 48:251–261, 2003.
Stoler MH: Human papillomaviruses and cervical neoplasia: A model for carcinogenesis.
Int J Gynecol Pathol 19:16–28, 2000.
Wright JD, Rosenblum K, Huettner PC, et al.: Cervical sarcomas: An analysis of
incidence and outcome. Gynecol Oncol 99:348–351, 2005.
Uterine Body
Abal M, Planaguma J, Gil-Moreno A, et al.: Molecular pathology of endometrial
carcinoma: Transcriptional signature in endometrioid tumors. Histol Histopathol 21:197–
204, 2006. Rubin 5e Suggested Readings P. 52 of 97
Baak JP, Mutter GL, Robboy S, et al.: The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in
endometrial hyperplasia more accurately than the 1994 World Health Organization
classification system. Cancer 103:2304–2312, 2005.
Clement PB, Young TH: Endometrioid carcinoma of the uterine corpus: A review of its
pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol
9:145–184, 2002.
Hecht JL, Ince TA, Baak JP, et al.: Prediction of endometrial carcinoma by subjective
endometrial intraepithelial neoplasia diagnosis. Mod Pathol 18:324–330, 2005.
Robboy SJ, Bentley RC, Butnor K, et al.: Pathology and pathophysiology of uterine
smooth-muscle tumors. Environ Health Perspect 108:779–784, 2000.
Silva EG: Diagnostic challenges in pathology. Int J Gynecol Cancer 15:403–405, 2005.
Silverberg SG, Mutter GL, Kurman RJ, et al.: Tumors of the uterine corpus: Epithelial
tumors and related lesions. In: Tavassoli FA, Stratton MR (eds). WHO Classification of
Tumors: Pathology and genetics of tumors of the breast and female genital organs. Lyon,
France: IARC Press, 2003:221–232.
Fallopian Tube
Agoff SN, Mendelin JE, Grieco VS, et al.: Unexpected gynecologic neoplasms in patients
with proven or suspected BRCA-1 or -2 mutations: Implications for gross examination,
cytology, and clinical follow-up. Am J Surg Pathol 26:171–178, 2002. Rubin 5e Suggested Readings P. 53 of 97
Demopoulos RI, Aronov R, Mesia A: Clues to the pathogenesis of fallopian tube carcinoma: A morphological and immunohistochemical case control study. Int J Gynecol
Pathol 20:128–132, 2001.
Ovary
Ehermann DA: Medical progress: Polycystic ovary syndrome. N Engl J Med 352:1223,
2005.
Hart WR: Mucinous tumors of the ovary: A review. Int J Gynecol Pathol 24:4–25, 2005.
Hart WR: Borderline epithelial tumors of the ovary. Mod Pathol 18:S33–50, 2005.
McCluggage WG, Wilkinson N: Metastatic neoplasms involving the ovary: A review
with an emphasis on morphological and immunohistochemical features. Histopathology
47:231, 2005.
Rapkiewicz AV, Espina V, Petricoin EF III, et al.: Biomarkers of ovarian tumours. Eur J
Cancer 40:2604, 2004.
Roth L: Recent advances in the pathology and classification of ovarian in sex cord-
stromal tumors of the ovary. Int J Gynecol Pathol 2006, in press.
Roth L, Talerman A: Germ cell tumors of the ovary. Int J Gynecol Pathol 2006, in press.
Shih IM, Kurman RJ: Molecular pathogenesis of ovarian borderline tumors: New insights
and old challenges. Clin Canc Res 11:7273–7279, 2005.
Silverberg SG: Histopathologic grading of ovarian carcinoma: A review and proposal. Int
J Gynecol Pathol 19:7–15, 2000. Rubin 5e Suggested Readings P. 54 of 97
Young RH: Sex cord-stromal tumors of the ovary and testis: Their similarities and
differences with consideration of selected problems. Mod Pathol 18:S81–98, 2005.
Placenta and Gestational Disease
Benirschke K, Masliah E: The placenta in multiple pregnancy: Outstanding issues.
Reprod Fertil Dev 13:615–622, 2001.
Hassadia A, Gillespie A, Tidy J, et al.: Placental site trophoblastic tumour: Clinical
features and management. Gyn Oncol 99:603–607, 2005.
Katz VL, Farmer R, Kuller JA: Preeclampsia into eclampsia: Toward a new paradigm.
Am J Obstet Gynecol 182:1389–1396, 2000.
Shih IM, Kurman RJ: The pathology of intermediate trophoblastic tumors and tumor-like
lesions. Int J Gynecol Pathol 20:31–47, 2001.
Shih IM, Kurman RJ: Placental site trophoblastic tumor: Past as prologue. Gynecol Oncol
82:413–414, 2001.
Peritoneum
Baker PM, Clement PB, Young RH: Malignant peritoneal mesothelioma in women: A
study of 75 cases with emphasis on their morphologic spectrum and differential
diagnosis. Amer J Clin Pathol 123:724–737, 2005.
Hoekstra AV, Riben MW, Frumovitz M, et al.: Well-differentiated papillary
mesothelioma of the peritoneum: A pathological analysis and review of the literature.
Gyn Oncol 98:161–167, 2005. Rubin 5e Suggested Readings P. 55 of 97
Misdraji J, Yantiss RK, Graeme-Cook FM, et al:Appendiceal mucinous neoplasms: A
clinicopathologic analysis of 107 cases. Amer J Surg Pathol 27:1089–1103, 2003.
Stern RC, Dash R, Bentley RC, et al.: Malignancy in endometriosis: Frequency and
comparison of ovarian and extraovarian types. Int J Gynecol Pathol 20:133–139, 2001.
Wells M: Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation. Int J Gynecol Pathol 23:316–20, 2004.
Young RH: Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Sem Diag Pathol 21:134–150, 2004.
Chapter 19
Books
Davidson, NE, Page DL, Recht A, et al.: The breast: Comprehensive management of
benign and malignant disorders, vols 1 and 2, 3rd ed. St. Louis: Saunders, 2004.
Hayes DF: Atlas of breast cancer, 2nd ed. New York: Mosby, 2000.
Rosai J: Breast. In: Ackerman’s surgical pathology, 9th ed. St. Louis: Mosby, 2002. book editor/s?> Rosen PP: Rosen’s breast pathology. Philadelphia: Lippincott Williams & Wilkins, 2001. Singletary SE, Robb GL, Hortobagyi GN: Advanced therapy of breast disease. London: Decker, 2004. Tavassoli FA: Pathology of the breast, 2nd ed. New York: Elsevier, 1999. Review Articles Rubin 5e Suggested Readings P. 56 of 97 Armstrong K, Eisen A, Weber B: Assessing the risk of breast cancer. N Engl J Med 342:564–570, 2000. Balmain A, Gray J, Ponder B: The genetics and genomics of cancer. Nat Genet 33:238– 244, 2003. Braunstein GD: Gynecomastia. N Engl J Med 328:490–495, 1993. Clemons M, Goss P: Estrogen and the risk of breast cancer. N Engl J Med 344:276–85, 2001. Colditz GA: Epidemiology and prevention of breast cancer. Cancer Epidemiol Prev 14:768–772, 2005. Domchek SM, Weber BL: Recent advances in breast cancer biology. Curr Opin Oncol 14:589–593, 2002. Jakub JW, Pendas S, Reintgen DS: Current status of sentinel lymph node mapping and biopsy: Facts and controversies. Oncologist 8:59–68, 2003. Keen JC, Davidson NE: The biology of breast carcinoma. Cancer 97:825–833, 2003. Key TJ, Allen NE: Hormones and breast cancer. IARC Sci Publ 156:273–276, 2002. Popescu NC, Zimonjic DB: Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy. Am J Med Genet 115:142–149, 2002. Ross JS, Fletcher JA, Bloom KJ, et al.: Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteom 3:379–398, 2004. Sauer G, Deissler H: Angiogenesis: Prognostic and therapeutic implications in gynecologic and breast malignancies. Curr Opin Obstet Gynecol 15:45–49, 2003. Rubin 5e Suggested Readings P. 57 of 97 Terribile D, Palumbo F, Nardone L: Prognostic role of sentinel lymph node biopsy in breast cancer. Rays 27:291–294, 2002. Original Articles Bellamy COC, McDonald C, Salter DM, et al.: Non-invasive ductal carcinoma of the breast. The relevance of histologic categorization. Hum Pathol 24:16–23, 1993. Boetes D, Beltman J: Screening women at increased risk with MRI. Cancer Imaging 5:S10–15, 2005 Chuo CB, Corder AP: Core biopsy vs fine needle aspiration cytology in a symptomatic breast clinic. Eur J Surg Oncol 29:374–378, 2003. Cummings SR, Lee JS, Liu L-Y, et al.: Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: A long-term prospective study. Cancer Epidemiol Biol Prev 14:1047–1051, 2005. Fisher B, Anderson S, Redmond CK, et al.: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456– 1461, 1995. Kallioniemi A: Molecular signature of breast cancer: Predicting the future (editorial). N Engl J Med 347:25, 2067–2068, 2002. Kerlikowske K, Smith-Bindman R, Ljung BM, et al.: Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med 139:274–284, 2003. Rubin 5e Suggested Readings P. 58 of 97 Kristoffersen WM, Aspelin P, Perbeck L, et al.: Value of MR imaging in clinical evaluation of breast lesions. Acta Radiol 43:275–281, 2003 Li CI, Weiss NS: Stanford JL, Daling JR. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88:2570– 2577, 2000. Page DL: Special types of invasive breast cancer, with clinical implications. Am J Surg Pathol 27:832–825, 2003. Parikh J, Tickman R: Image-guided tissue sampling: Where radiology meets pathology. Breast J 11:403–409, 2005. Peppercorn J, Partridge A, Burstein HJ, et al.: Standards for follow-up care of patients with breast cancer. Breast 14:500–508, 2005. Sandias EE, DeBree E, Tsiftsis DD: How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer. Am J Surg 185:202–210, 2003. Schnitt SJ: Benign breast disease and breast cancer risk: Morphology and beyond. Am J Surg Pathol 27:836–841, 2003. Shattuck-Eidens D, McClure M, Simard J, et al.: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273:535– 541, 1995. Tohno E, Ueno E: Ultrasound (US) Diagnosis of nonpalpable breast cancer. Breast Cancer 12:267–271, 2005. Van de Vijver M, et al.: A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009, 2002. Rubin 5e Suggested Readings P. 59 of 97 Van’t Veer LJ, Dai H, van de Vijver MJ, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:2002. Yang Q, Yoshimura G, Nakamura M, et al.: BRCA1 in non-inherited breast carcinomas. Oncol Rep 9:1329–1333, 2002. Chapter 20 Beutler E, Lichtman MA, Coller BS, et al.: Williams hematology, 6th ed. New York: McGraw-Hill, 2001. Brunning RD, McKenna RW: Tumors of the bone marrow. Washington, DC: Armed Forces Institute of Pathology, 1994. Colman R, Hirsh J, Marder VJ, et al.: Hemostasis and thrombosis, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001. Crossman LC, O’Brien SG: Imatinib therapy in chronic myeloid leukemia. Hematol Oncol Clin North Am 18:605–617, 2004. Ferry JA, Harris NL: Atlas of lymphoid hyperplasia and lymphoma. Philadelphia: WB Saunders, 1997. Foucar K: Bone marrow pathology. Chicago: ASCP (American Society of Pathology) Press, 2001. Harmening D: Clinical hematology and fundamentals of hemostasis, 4th ed. Philadelphia: FA Davis, 2001. Hoffbrand AV, Pettit JE: Color atlas of clinical hematology, 3rd ed. London: Mosby- Wolfe, 2000. Rubin 5e Suggested Readings P. 60 of 97 Jaffe ES, Harris NL, Stein H, et al.: World Health Organization classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001. Jandl JH: Textbook of hematology, 2nd ed. Boston: Little, Brown, 1996. Keren DF, McCoy JP, Carey JL: Flow cytometry in clinical diagnosis, 3rd ed. Chicago: ASCP (American Society of Pathology) Press, 2001. Knowles DM: Neoplastic hematology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001. McKenzie SB: Textbook of hematology, 2nd ed. Baltimore: Williams & Wilkins, 1996. Warnke RA, Weis LM, Chan JKC, et al.: Tumors of the lymph nodes and spleen. Washington, DC: Armed Forces Institute of Pathology, 1995. Review Articles Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403;503–511, 2000. Bennett JM: World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 72;131–133, 2000. Bick RL: Laboratory evaluation of platelet dysfunction. Clin Lab Med 15;1–38, 1995. Chan JK: The new World Health Organization classification of lymphomas: The past, the present and the future. WHO: 2001. Giardini C, Galimberti M, Lucarelli G: Bone marrow transplantation in thalassemia. Annu Rev Med 46;319–330, 1995. Rubin 5e Suggested Readings P. 61 of 97 Harris NL, Jaffe ES, Stein H, et al.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84;1361–1392, 1994. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 346;752–763, 2002. Masters JR, Lakhani SR: How diagnosis with microarrays can help cancer patients. Nature 404;921, 2000. Olivieri NF: The beta-thalassemias. N Engl J Med 341;99–109, 1999. Rodak BF, Leclair SJ: The new WHO nomenclature: Introduction and myeloid neoplasms. Clin Lab Sci 15;44–54, 2002. Rosenwald A, Staudt LM: Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol 29;258–263, 2002. Tefferi A: Anemia in adults: A contemporary approach to diagnosis. Mayo Clin Proc 78;1274–1280, 2003. Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100;2292–2302, 2002. Rubin 5e Suggested Readings P. 62 of 97 Chapter 21 Books DeGroot LJ: Endocrinology. 4th ed. Philadelphia: WB Saunders, 2001. DeLellis RA: Tumors of the parathyroid gland. Atlas to tumor pathology, 3rd series. Fascicle 16. Washington, DC: Armed Forces Institute of Pathology, 1993. DeLellis RA, Lloyd RV, Heitz PU, et al.: Pathology and genetics of tumours of endocrine organs. Lyon, France: WHO/OMS, IARC Press, 2004. Felig P, Baxter JD, Frohman LA: Endocrinology and metabolism, 4th ed. New York: McGraw-Hill, 2001. Kleihues P, Cavenee WK: Pathology and genetics of the nervous system. Lyon, France: WHO/OMS, IARC Press, 2000. Kornstein MJ: Pathology of the thymus and mediastinum. Philadelphia: WB Saunders, 1995. Lack EE: Tumors of adrenal glands and extra-adrenal paraganglia. Atlas of tumor pathology, 3rd series. Fascicle. Washington, DC: Armed Forces Institute of Pathology, 1997. Livolsi VA, Asa SL: Endocrine pathology. Philadelphia: Churchill-Livingstone, 2002. Lloyd RV, Douglas BR, Young WF: Endocrine diseases. AFIP, 2002. Rosai J, Carcangina ML, DeLellis RA: Tumors of the thyroid gland. Atlas of tumor pathology, 3rd series. Fascicle. Washington, DC: Armed Forces Institute of Pathology, 1993. Wenig BM, Heffnes CS, Adair CF: Atlas of endocrine pathology. Philadelphia: WB Saunders, 1997. Rubin 5e Suggested Readings P. 63 of 97 Wilson JD, Foster DW: Williams textbook of endocrinology, 9th ed. Philadelphia: WB Saunders, 1998. Pathology and genetics, Tumours of Endocrine Organs, WHO classification of tumors. 2004. Review Articles Allolio B, Fassnacht M: Adrenocortical carcinoma: Clinical update. J Clin Endocrinol Metab 21;2006. Alsanea O, Clark OH: Familial thyroid cancer. Curr Opin Oncol 13:44–51, 2001. Allolio B, Fassnacht M: Adrenocortical carcinoma: Clinical update. J Clin Endocrinol Metab 21;2006. Asa SL, Ezzat S: Genetics and proteomics of pituitary tumors. Endocrine 28:43–47. 2005 Baloch ZW, LiVolsi VA: Follicular patterned lesions of the thyroid. Am J Clin Pathol 117:143–150, 2002. Boscaro M, Barzon L, Falio F, et al.: Cushing’s syndrome. Lancet 357:783–791, 2001. Collins MT, Sarlis NJ, Merino MJ, et al.: Thyroid carcinoma in the McCune-Albright syndrome: Contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab 88:4413–4417, 2003. Dayan CM, Daniels GH: Chronic autoimmune thyroiditis. N Engl J Med 335:99–107, 1996. Eng C: The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung’s disease. N Engl J Med 335:943–951, 1996. Rubin 5e Suggested Readings P. 64 of 97 Faglia G, Spada A: Genesis of pituitary adenomas: State of the art. J Neurooncol 54:95– 110, 2001. Ganguly A: Primary aldosteronism. N Engl J Med 339:1828, 1998. Gimm O: Thyroid cancer. Cancer Lett 163:143–156, 2001. Hoff AO, Cote GJ, Gagel RF: Multiple endocrine neoplasias. Annu Rev Physiol 62:377– 411, 2000. Hull KL, Harvey S: Growth hormone resistance: Clinical states and animal models. J Endocrinol 163:165–172, 1999. Johnson SB, Eng TY, Giaccone G, et al.: Thymoma: Update for the new millennium. Oncologist 6:239–246, 2001. Kontogeorgos G: Classification and pathology of pituitary tumors. Endocrine 28:27–35, 2005. Lloyd RV: Molecular pathology of pituitary adenomas. J Neurooncol 54:111–119, 2001. Lombardi CP, Raffaelli M, Pani G, et al.: Gene expression profiling of adrenal cortical tumors by cDNA macroarray analysis. Results of a preliminary study. Biomed Pharmacother 31;2006. Marx S: Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863–1875, 2000. Neumann PH, Hoegerle S, Manz T, et al.: How many pathways to pheochromocytoma. Semin Nephrol 22:89–99, 2002. Parks JS, Brown MR, Hurley DL, et al.: Heritable disorders of pituitary development. J Clin Endocrinol Metab 84:4362–4370, 1999. Rubin 5e Suggested Readings P. 65 of 97 Peterson P, Uibo R, Krohn K: Adrenal autoimmunity: Results and developments. Trends Endocrinol Metab 11:285–290, 2000. Phay JE, Moley JF, Lairmore TC: Multiple endocrine neoplasias. Semin Surg Oncol 18:324–332, 2000. Puxeddu E, Fagin J: Genetic markers in thyroid neoplasia. Endocrinol Metab Clin North Am 30:493–513, 2001. Reincke M, Beuschlein F, Slawik M, et al.: Molecular adrenocortical tumourigenesis. Eur J Clin Invest 30:63–68, 2000. Savage MO, Burren CP, Blair JC, et al.: Growth hormone insensitivity: Pathophysiology, diagnosis, clinical variation and future perspectives. Horm Res 55:32–35, 2001. Schusshem DH, Skarulis MC, Agarwal SK, et al.: Multiple endocrine neoplasia type 1: New clinical and basic findings. Trends Endocr Metab 12:173–178, 2001. Schwab M, Westermann F, Hero B, et al.: Neuroblastoma: Biology and molecular and chromosomal pathology. Lancet Oncol 4:472–480, 2003. Shane E: Clinical review 122: Parathyroid carcinoma. J Clin Endocr Metab 86:485–493, 2001. Speiser PW: Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin 30:31–59, 2001. Stassi G, DeMaria R: Autoimmune thyroid disease: New models of cell death in autoimmunity. Nat Rev/Immunol 2:195–204, 2002. Tamler R, Lewis MS, LiVolsi VA, et al.: Parathyroid carcinoma: Ultrasonographic and histologic features. Thyroid 15:744–745, 2005. Rubin 5e Suggested Readings P. 66 of 97 Ten S, New M, Maclaren N: Addison’s disease 2001. J Clin Endocrinol Metab 86:2909– 2922, 2001. Williams ED, Abrosimov A, Bogdanova T, et al.: Thyroid carcinoma after Chernobyl: Latent period, morphology and aggressiveness. Br J Cancer 90:2219–2124, 2004. Chapter 22 Book Goldstein BJ, Gorstein F: Diabetes Mellitus, Clinics in Laboratory Medicine, vol. 21, no. 1. Philadelphia: WB Saunders, 2001. Goldstein BJ, Müller-Wieland D: Textbook of type 2 diabetes. London: Martin Dunitz, 2003. Monograph National Institutes of Health, National Heart, Lung, and Blood Institute: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 6:51S–209S, 1998. Review Articles Atkinson MA: Thirty years of investigating the autoimmune basis for type 1 diabetes: Why can’t we prevent or reverse this disease? Diabetes 54:1253–1263, 2005. Atkinson MA, Eisenbarth GS: Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 358:221–229, 2001. Rubin 5e Suggested Readings P. 67 of 97 Bray GA: Medical consequences of obesity. J Clin Endocrinol Metab 89:2583–2589, 2004. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54:1615–1625, 2005. Considine RV: Regulation of energy intake: http://www.endotext.com/, 2002. Accessed 12/2005. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 365:1415–1428, 2005. Elmquist JK, Flier JS: The fat-brain axis enters a new dimension. Science 304:63–64, 2004. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167, 2003. Farooqi IS, O’Rahilly S: Monogenic obesity in humans. Annu Rev Med 56:443–458, 2005. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356–359, 2002. Garg A: Regional adiposity and insulin resistance. J Clin Endocrinol Metab 89:4206– 4210, 2004. Kahn R, Buse J, Ferrannini E, et al.: The metabolic syndrome: Time for a critical appraisal. Diabetes Care 28:2289–2304, 2005. Kahn SE: The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047–4058, 2001. Rubin 5e Suggested Readings P. 68 of 97 Kaufman FR: Type 2 diabetes in children and youth. Endocrinol Mnetab Clin North Am 34:659–676, 2005. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556, 2004. Klein S, Wadden T, Sugerman HJ: AGA technical review on obesity. Gastroenterology 123:882–932, 2002. Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science 307:384–387, 2005. Marker J, Maclaren N: Immunopathology of immune-mediated (type 1) diabetes. Clin Lab Med 21:15–30, 2001. Martin S, Wolf-Eichbaum D, Duinkerken G, et al.: Development of type 1 diabetes despite severe hereditary B-cell deficiency. N Engl J Med 345:1036–1040, 2001. Marx J: Cellular warriors at the battle of the bulge. Science 299:846–849, 2003. McGowan T, McCue P, Sharma K: Diabetic nephropathy. Clin Lab Med 21:111–146, 2001. Pagotto U, Vicennati V, Pasquali R: The endocannabinoid system and the treatment of obesity. Ann Med 37:270–275, 2005. Pratley RE: Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: Lessons learned from the Pima Indians. Proc Nutr Soc 57:175–181, 1998. Ravussin E, Smith SR: Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363–378, 2002 Rubin 5e Suggested Readings P. 69 of 97 Rhodes CJ: Type 2 diabetes: A matter of β-cell life and death? Science 307:380–384, 2005. Saltiel AR: New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529, 2001. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806, 2001. Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333–1346, 2005. Trujillo ME, Scherer PE: Adiponectin: Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167–175, 2005. Unger RH: Minireview: Weapons of lean body mass destruction: The role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159–5165, 2003. Wynne K, Stanley S, Bloom S: The gut and regulation of body weight. J Clin Endocrinol Metab 89:2576–2582, 2004. Zimmet P, Alberti KGMM, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782–787, 2001. Chapter 23 Bellotti V, Mangione P, Merlini G: Review: Immunoglobulin light chain amyloidosis: The archetype of structural and pathogenic variability. J Struct Biol 130:280–289, 2000. Benson MD, Uemichi T: Transthyretin amyloidosis. Amyloid 3:44–56, 1996. Buxbaum JN, Tagoe CE: The genetics of the amyloidoses. Annu Rev Med 51:543–569, 2000. Rubin 5e Suggested Readings P. 70 of 97 Caughey B: Interactions between prion protein isoforms: The kiss of death? Trends Biochem Sci 26:235–242, 2001. Guidelines for authors. Amyloid: J Prot Folding Dis 12, 2005. Damas AM, Saraiva MJ: Review: TTR amyloidosis: Structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol 130:290–299, 2000. Hull RL, Westermark GT, Westermark P, et al.: Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab. 89:3629–3643, 2004. Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48:241–253, 1999. Kisilevsky R: Review: Amyloidogenesis-unquestioned answers and unanswered questions. J Struct Biol 130: 99–108, 2000. Kisilevsky R, Fraser PE: Aβ amyloidogenesis: Unique or variation on a systemic theme? Crit Rev Biochem Mol Biol 32:361–404, 1997. Kisilevsky R, Gruys E, Shirahama T: Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid 2:128–133, 1995. Merlini G, Belloti V: Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596, 2003. Prusiner SB: Shattuck lecture: Neurodegenerative diseases and prions. N Engl J Med 344:1516–1526, 2001. Skinner M: AL amyloidosis: The last 30 years. Amyloid 7:13–14, 2000. Rubin 5e Suggested Readings P. 71 of 97 Spillantini MG, Tolnay M, Love S, et al.: Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol 97:585–594, 1999. Chapter 24 Books Austen KF, Eisen AZ, Freedberg IM, et al.: Dermatology in general medicine, 6th ed. New York: McGraw-Hill, 2003. Barnhill RL, Crowson AN: Dermatopathology. New York: McGraw-Hill, 2004. Barnhill RL, Piepkorn M, Busam KJ: Pathology of melanocytic nevi and malignant melanoma, 2nd ed. New York: Springer, 2004. Berger TG, James WD, Odom RB: Diseases of the skin, 10th ed. Philadelphia: Elsevier Saunders, 2005. Bolognia JL, Jorizzo JL, Rapini RP, et al.: Dermatology. St. Louis: Mosby, 2003. Elder D, Elenitsas R, Johnson B, et al.: Histopathology of the skin, 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2005. Goldblum JR, Weiss SW.: Soft tissue tumors, 4th ed. St. Louis: Mosby, 2001. Smoller BR, Horn TD: Dermatopathology in systemic disease. New York: Oxford University Press, 2001. Sternberg SS: Histology for pathologists, 2nd ed. Philadelphia: Lippincott-Raven, 1997. Weedon D: Skin pathology, 2nd ed. New York: Churchill-Livingstone, 2002. Reviews Rubin 5e Suggested Readings P. 72 of 97 Anatomy and Physiology of the Skin Cotsarelis G, Paus R: The biology of hair follicles. N Engl J Med 341:491–497, 1999. Fine JD: The skin basement membrane zone. Adv Dermatol 2:283–304, 1987. Johnson KO: The roles and functions of cutaneous mechanoreceptors. Curr Opin Neurobiol 11:455–461, 2001. McMillan JR, Shimizu H: Desmosomes: structure and function in normal and diseased epidermis. J Dermatol 28:291–298, 2001. Rietschel RL: A simplified approach to the diagnosis of alopecia. Dermatol Clin 14:691– 695, 1996. Romani N, Ratzinger G, Pfaller K, et al.: Migration of dendritic cells into lymphatics— The Langerhans cell example: Routes, regulation, and relevance. Int Rev Cytol 207:237– 270, 2001. Sidhu GS, Chandra P, Cassai ND: Merkel cells, normal and neoplastic: An update. Ultrastruct Pathol 29:287–294, 2005. Smack DP, Korge BP, James WD: Keratin and keratinization. J Am Acad Dermatol 30:85–102, 1994. Uchi H, Terao H, Koga T, et al.: Cytokines and chemokines in the epidermis. J Dermatol Sci 24:S29–38, 2000. Diseases of the Epidermis Bos JD, de Rie MA, Teunissen MBM, et al.: Psoriasis: Dysregulation of innate immunity. Br J Dermatol 152:1098–1107, 2005. Rubin 5e Suggested Readings P. 73 of 97 Bowcock AM, Krueger JG: Getting under the skin: the immunogenetics of psoriasis. Nature Rev Immunol 5:699–711, 2005. Bystryn JC, Rudolph JL: Pemphigus. Lancet 366:61–73, 2005. Hertl M: Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 122:91–100, 2000. Hovnanian A: Darier’s disease: from dykeratosis to endoplasmic reticulum calcium ATPase deficiency. Biochem Biophys Res Commun 322:1237–1244, 2004. Richard G: Molecular genetics of the ichthyoses. Am J Med Genet C Semin Med Genet 131C:32–44, 2004. Diseases of the Basement Membrane Zone Bhattacharya M, Kaur I, Kumar B: Lichen planus: A clinical and epidemiological study. J Dermatol 27:576–582, 2000. DeRossi SS, Ciarrocca KN: Lichen planus, lichenoid drug reactions, and lichenoid mucositis. Dent Clin North Am 49:77–89, 2005. Fine J, Eady RAJ, Bauer, EA, et al.: Revised classification system for inherited epidermolysis bullosa: Report of the second international consensus meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 42:1051–1066, 2000. Karpati S: Dermatitis herpetiformis: Close to unravelling a disease. J Dermatol Sci 34:83–90, 2004. Lane EB, McLean WHI: Keratins and skin disorders. J Pathol 204:355–366, 2004. Rubin 5e Suggested Readings P. 74 of 97 Leaute-Labreze C, Lamireau T, Chawki D, et al.: Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 83:347–352, 2000. Liu CC, Manzi S, Ahearn JM: Biomarkers for systemic lupus erythematosus: A review and perspective. Curr Opin Rheumatol 17:543–549, 2005. Millard TP, McGregor JM: Molecular genetics of cutaneous lupus erythematosus. Clin Exp Dermatol 26:184–191, 2001. Nicolas MEO, Krause PK, Gibson, LE, et al.: Dermatitis herpetiformis. Int J Dermatol 42:588–600, 2003. Powell AM, Sakuma-Oyama Y, Oyama N, et al.: Collagen XVII/BP180: A collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clin Exp Dermatol 30:682–687, 2005. Sun Y, Chan RKW, Tan SH, et al.: Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR. J Med Virol 71:423– 428, 2003. Tebbe B: Clinical course and prognosis of cutaneous lupus erythematosus. Clin Dermatol 22:121–124, 2004. Thoma-Uszynski S, Uter W, Schwietzke S, et al.: BP230- and BP180-specific auto- antibodies in bullous pemphigoid. J Invest Dermatol 122:1413–1422, 2004. Inflammatory Diseases of the Superficial and Deep Vascular Bed Belsito DV: Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability. J Am Acad Dermatol 53:303–313, 2005. Rubin 5e Suggested Readings P. 75 of 97 Carder KR: Hypersensitivity reactions in neonates and infants. Dermatol Ther 18:160– 175, 2005. English JC, Patel PJ, Greer KE: Sarcoidosis. J Am Acad Dermatol 44:725–743, 2001. Fang KS, Lawry M, Haas A: Papules on the hands. Granuloma annulare. Arch Dermatol 137:1647–1652, 2001. Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM: Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol 17:56–61, 2004. Hsu S, Le EH, Khoshevis MR: Differential diagnosis of annular lesions. Am Fam Physician 64:289–296, 2001. Kaplan AP, Greaves MW: Angioedema, J Am Acad Dermatol 53:373–388, 2005. Wakelin SH: Contact urticaria. Clin Exp Dermatol 26:132–136, 2001. Wolf R, Orion E, Marcos B, et al.: Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 23:171–181, 2005. Disorders of the Dermal Connective Tissue Hawk A, English JC: Localized and systemic scleroderma. Semin Cutan Med Surg 20:27–37, 2001. Senecal JL, Henault J, Raymond Y: The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma). J Rheumatol 32:1643–1649, 2005. Inflammatory Disorders of the Panniculus Requena L, Sanchez Yus E: Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 45:163–183, 2001. Rubin 5e Suggested Readings P. 76 of 97 Requena L, Sanchez Yus E: Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 45:325–361, 2001. Acne Vulgaris Federman DG, Kirsner RS: Acne vulgaris: Pathogenesis and therapeutic approach. Am J Manag Care 6:78–87, 2000. Infections and Infestations Edlich RF, Winters KL, Britt LD, et al.: Bacterial diseases of the skin. J Long Term Eff Med Implants 15:499–510, 2005. Sangueza OP, Fleet SL, Requena L: Update on the histologic findings of cutaneous infections. Adv Dermatol 16: 361–423, 2000. Venkatesan P, Perfect JR, Myers SA: Evaluation and management of fungal infections in immunocompromised patients. Dermatol Ther 18:44–57, 2005. Primary Neoplasms of the Skin Allen PJ, Bowne WB, Jaques DP, et al.: Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. J Clin Oncol 23:2300–2309, 2005. Aloia TA, Gershenwald JE: Management of early-stage cutanous melanoma. Curr Probl Surg 42:468–534, 2005. Anadolu RY, Birol A, Sanli H, et al.: Mycosis fungoides and Sezary syndrome: Therapeutic approach and outcome in 113 patients. Int J Dermatol 44:559–565, 2005. Rubin 5e Suggested Readings P. 77 of 97 Begg CB, Orlow I, Hummer AJ, et al.: Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 97:1507–1515, 2005. Billings SD, Folpe AL: Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy. Am J Dermatopathol 26:141–155, 2004. Chudnovsky Y, Adams AE, Robbins PB, et al.: Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet 37:745–749, 2005, Clayman GL, Lee JJ, Holsinger FC, et al.: Mortality risk from squamous cell carcinoma. J Clin Oncol 23:759–765, 2005. Culpepper KS, Granter SR, McKee PH: My approach to atypical melanocytic lesions. J Clin Pathol 57:1121–1131, 2004. Daniotti M, Oggionni M, Ranzani T, et al.: BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 23:5968–5977, 2004. Florell SR, Boucher KM, Garibotti G, et al.: Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 23:7168–7177, 2005. Gimotty PA, Botbyl J, Soong S, et al.: A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 23:8065–8075, 2005. Gimotty PA, Van Belle P, Elder DE, et al.: Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorgenicity in thin invasive cutaneous melanoma. J Clin Oncol 23:8048–8056, 2005. Goessling W, McKee PH, Mayer RJ: Merkel cell carcinoma. J Clin Oncol 20:588–598, 2002. Rubin 5e Suggested Readings P. 78 of 97 Hussein MR: Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: Emerging clues. J Clin Pathol 58:453–456, 2005. Jorizzo JL: Current and novel treatment options for actinic keratosis. J Cutan Med Surg 8:13–21, 2005. Kumar R, Angelini S, Snellman E, et al.: BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122:342–348, 2004. Querfeld C, Rosen ST, Guitart J, et al.: The spectrum of cutaneous T-cell lymphomas: New insights into biology and therapy. Curr Opin Hematol 12:273–278, 2005. Rager EL, Bridgeford EP, Ollila DW: Cutaneous melanoma: Update on prevention, screening, diagnosis, and treatment. Am Fam Physician 72:269–276, 2005. Reifenberger J, Wolter M, Knobbe CB, et al.: Somatic mutations in the PTCH, SMOH, SUFUH, and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 152:43–51, 2005. Sanchez Yus E, Simon P, Requena L, et al.: Solitary keratoacanthoma. Am J Dermatopathol 22:305–310, 2000. Schaffer JV, Bolognia JL: The clinical spectrum of pigmented lesions. Clin Plast Surg 27:391–408, 2000. Schuchter LM: Review of the 2001 AJCC staging system for cutaneous malignant melanoma. Curr Oncol Rep 3:332–337, 2001. Scoggins CR, Chagpar AB, Martin RC, et al.: Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? Nat Clin Pract Oncol 2:448– 455, 2005. Rubin 5e Suggested Readings P. 79 of 97 Storm CA, Seykora JT: Cutaneous adnexal neoplasms. Am J Clin Pathol 118:S33–49, 2002. Strange RC, El-Genidy N, Ramachandran S, et al.: Susceptibility to basal cell carcinomas: Associations with PTCH polymorphisms. Ann Hum Genet 68:536–545, 2004. Strungs I: Common and uncommon variants of melanocytic naevi. Pathology 36:396– 403, 2004. Tsutsumida A, Furukawa H, Yamamota Y, et al.: Treatment strategy for cutaneous malignant melanoma. Int J Clin Oncol 10:311–317, 2005. Wong SL: The role of sentinel lymph node biopsy in the management of thin melanoma. Am J Surg 190:196–199, 2005. Cutaneous Manifestations of HIV Infection Ensoli B, Sgadari C, Barillari G, et al.: Biology of Kaposi’s sarcoma. Eur J Cancer 37:1251–1269, 2001. Rigopoulos D, Paparizos V, Katsambas A: Cutaneous markers of HIV infection. Clin Dermatol 22:487–498, 2004. Rubin 5e Suggested Readings P. 80 of 97 Chapter 25 Books Barnes L: Surgical pathology of the head and neck, 2nd ed. New York: Marcel Dekker, 2001. Barnes L, Eveson JW, Reichart P, et al.: Pathology & genetics of head and neck tumours. World Health Organization Classificartion of Tumours. Lyon, France: IARC Press, 2005. Ellis GL, Auclair PL, Gnepp DR: Surgical pathology of the salivary glands. Philadelphia: WB Saunders, 1991. Friedmann I, Arnold W: Pathology of the ear. Edinburgh: Churchill-Livingstone, 1992. Fu Y-S, Wenig BM, Abemayor E, Wenig BL: Head and neck pathology with clinical correlations. Philadelphia: Churchill-Livingstone, 2001. Gnepp DR: Diagnostic surgical pathology of the head and neck. Philadelphia: WB Saunders, 2001. Grundmann E, Krueger GRF, Ablashi DV: Nasopharyngeal carcinoma. Stuttgart: Gustav Fischer Verlag, 1981. Hawke M, Jahn AF: Disease of the ear: Clinical and pathological aspects. Philadelphia: Lea & Febiger, 1986. Hollinshead WH: Anatomy for surgeons, vol 1, 3rd ed. Philadelphia: Harper & Row, 1982. Hooks JJ, Jordan GH: Viral infections in the oral cavity. New York: Elsevier-North Holland, 1982. Rubin 5e Suggested Readings P. 81 of 97 Konigsmark BW, Gorlin RJ: Genetic and metabolic deafness. Philadelphia: WB Saunders, 1976. McCarthy PL, Shklar G: Diseases of the oral mucosa, 2nd ed. Philadelphia: Lea & Febiger, 1980. Michaels L: Ear, nose and throat histopathology. New York: Springer-Verlag, 1987. Nager GT: Pathology of the ear and temporal bone. Baltimore: Williams & Wilkins, 1993. Neville BW, Damm DD, Allen CM, et al.: Oral and maxillofacial pathology, 2nd ed. Philadelphia: WB Saunders, 2002. Regezi JA, Sciubba J: Oral pathology: Clinical-pathologic correlations, 2nd ed. Philadelphia: WB Saunders, 1993. Robertson PB, Greenspan JS: Perspectives on oral manifestations of AIDS: Diagnosis and management of HIV-associated infections. Littleton, MA: PSG Publishing, 1988. Robinson HBG, Miller AS: Colby, Kerr and Robinson’s color atlas of oral pathology, 5th ed. Philadelphia: JB Lippincott, 1990. Schuknecht HF: Pathology of the ear. Cambridge, MA: Harvard University Press, 1974. Tala H, Moutsopoulos HM, Kassan SG: Sjögren’s syndrome: Clinical and immunological aspects. New York: Springer-Verlag, 1987. Wenig BM: Atlas of head and neck pathology, 2nd ed. . London: Elsevier, in press. update?> Wenig BM, Cohen J-M: General principles of head and neck pathology. In: Harrison LB, Sessions RB, Hong WK (eds): Head and neck cancer, 2nd ed. Philadelphia: Lippincott- Raven, 2004. Review Articles General Batsakis JG, Luna MA: Midfacial necrotizing lesions. Semin Diagn Pathol 4:90–103, 1987. Feinmesser R, Miyazaki I, Cheung R, et al.: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 326:17– 21, 1992. Saul SH, Kapadia SB: Primary lymphoma of Waldyer’s ring. Cancer 56:157, 1985. Swanson JA, Hoecker JL: Otitis media in young children. Mayo Clin Proc 71:179–183, 1996. Wenig BM: Squamous cell carcinoma of the upper aerodigestive tract: Precursors and problematic variants. Mod Pathol 15:229–254, 2002. Wenig BM: The ear. In: Mills SE (ed). Sternberg’s diagnostic surgical pathology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Wenig BM: Nose/sinuses. In: Fletcher CM (ed): Diagnostic histopathology of tumors, 3rd ed. London: Churchill-Livingstone, in press. Wenig BM: Nasal cavity, paranasal sinuses, and nasopharynx. In: Weidner N, Cote RJ, Suster S, et al. (eds): Modern surgical pathology. Philadelphia: Elsevier, in press. update?> Oral Cavity Kramer IRH, Lucas RB, Pindborg JJ, et al.: Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg 46:518, 1978. Rubin 5e Suggested Readings P. 83 of 97 Shaw JH: Causes and control of dental caries. N Engl J Med 316:996–1004, 1987. Nasal Cavity and Paranasal Sinuses Batsakis JG, Luna MA: Midfacial necrotizing lesions. Semin Diagn Pathol 4:90–103, 1987. Fienberg R, et al.: Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener’s (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 24:160–168, 1993. Lee NK, et al.: Head and neck squamous cell carcinomas associated with human papillomaviruses and an increased incidence of cervical pathology. Otolaryngol Head Neck Surg 99:296–301, 1988. Naclerio RM: Allergic rhinitis. N Engl J Med 325:860–869, 1991. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 328:184–186, 1993. Wald ER: Sinusitis in children. N Engl J Med 326:319–323, 1992. Wu TC, et al.: Association of human papillomavirus with nasal neoplasia. Lancet 341:522–524, 1993. Nasopharynx Chan ACL, Chan JKC, Cheung MMC: Hematolymphoid tumours. In: Barnes L, Eveson JW, Reichart P, et al. (eds). Pathology & genetics of head and neck tumours. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2005. Rubin 5e Suggested Readings P. 84 of 97 Chan JKC, Pilch BZ, Bray F, et al.: Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, et al. (eds). Pathology & genetics of head and neck tumours. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2005. De The G, Ito Y (eds): Nasopharyngeal carcinoma: Etiology and control. Lyon, France: IARC Scientific Publications, 1978. Feinmesser R, Miyazaki I, Cheung R, et al.: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 326:17– 21, 1992. Saul SH, Kapadia SB: Primary lymphoma of Waldeyer’s ring. Cancer 56:157, 1985. Ear Melamed Y, Shupak A, Bitterman H: Medical problems associated with underwater diving. N Engl J Med 326:30–35, 1992. Nadol JB: Hearing loss. N Engl J Med 329:1092–1102, 1993. Swanson JA, Hoecker JL: Otitis media in young children. Mayo Clin Proc 71:179–183, 1996. Original Articles Bedi GC, Westra WH, Gabrielson E, et al.: Multiple head and neck tumors: Evidence for common clonal origin. Can Res 26:251–261, 1995. Califano J, van der Riet P, Westra W, et al.: Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56:2484–2487, 1996. Rubin 5e Suggested Readings P. 85 of 97 Decker J, Goldstein JC: Risk factors in head and neck cancer. N Engl J Med 306:1151– 1155, 1982. Dyson N, Howley PM, Münger K, et al.: The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 243:934–937, 1989. Gillison ML, Koch WM, Capone RB, et al.: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709– 720, 2000. MacMillan C, Kapadia SB, Finkelstein SD, et al.: Lymphoepithelial carcinoma of the larynx and hypopharynx: Study of eight cases with relationship to Epstein-Barr virus (EBV) and p53 gene alterations, and review of the literature. Hum Pathol 27:1172–1179, 1996. McKaig RG, Baric RS, Olshan AF: Human papillomavirus and head and neck cancer: Epidemiology and molecular biology. Head Neck 20:250–265, 1998. Mork J, Lie K, Glattre E, et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131, 2001. Pacchioni D, Negro F, Valente G, et al.: Epstein-Barr virus by in situ hybridization in fine-needle aspiration biopsies. Diagn Mol Pathol 3:100–104, 1994. Chapter 26 Books Avioli LV, Krane SM: Metabolic diseases and clinically related disorders, 3rd ed. Philadelphia: WB Saunders, 1997. Collins DH: Pathology of bone. London: Butterworth, 1966. Rubin 5e Suggested Readings P. 86 of 97 Dahlin DC, Unni KK: Bone tumors: General aspects and data on 8,542 cases, 4th ed. Springfield, IL: Charles C Thomas, 1986. Dorfman HD, Czerniak B: Bone tumors. St. Louis: Mosby, 1998. Farvus M: Primer on the metabolic bone diseases and disorders of mineral metabolism: American Society for Bone and Mineral Research, 1990. Fechner RE, Mills SE: Tumors of bones and joints. Atlas of tumor pathology. Fascicle 8, 3rd series. Washington, DC: Armed Forces Institute of Pathology, 1993. Fletcher CDM, Unni KK, Mertens F: World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon, France: IARC Press, 2002. Glimcher MJ: On the form and function of bone: From molecules to organs: Wolff’s law revisited. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB: Textbook of rheumatology, 5th ed. Philadelphia: WB Saunders, 1997. Jaffe HL: Tumors and tumorous conditions of the bones and joints. Philadelphia: Lea & Febiger, 1958. Kempson RL, Fletcher CM, Evans HL, et al.: Tumors of the soft tissues. Atlas of tumor pathology. Fascicle 30. 3rd series. Washington, DC: Armed Forces Institute of Pathology, 2001. Marcus R, Feldman D, Kelsey J: Osteoporosis. San Diego: Academic Press, 1996. Rodman GP, Shumacher HR: Primer on the rheumatic diseases, 8th ed. Atlanta: Arthritis Foundation, 1983. Scriver CR, Beaudet AL, Sly SW, et al.: The metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill, 1989. Rubin 5e Suggested Readings P. 87 of 97 Unni KK: Dahlin’s bone tumors. General aspects and data on 11,087 cases, 5th ed. Philadelphia: Lippincott-Raven, 1996:263–283. Veis A: Chemistry and biology of mineralized connective tissue. New York: Elsevier- North Holland, 1981. Vogelstein B, Kinzler KW: The Genetic Basis of Human Cancer, 2nd ed. New York: McGraw-Hill Medical Publishing, 2002. Weiss SW, Goldblum JR: Enzinger and Weiss’s soft tissue tumors, 4th ed. St. Louis: CV Mosby, 2001. Review Articles The ADHR Consortium: Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348, 2000. Barton NW, Brady RO, Dambrosia JM, et al.: Replacement therapy for inherited enzyme deficiency: Macrophage-targeted glucocerebrosidase for Gaucher’s disease. N Engl J Med 324:1464–1470, 1991. Biermann JS: Common benign lesions of bone in children and adolescents. J Pediatr Orthop 22:268–273, 2002. Brandt KD: Proceedings of an international workshop on osteoarthritis outcomes. J Rheumatol 31:1–92, 2004. Byers PH: Osteogenesis imperfecta: perspectives and opportunities. Curr Opin Pediatr 12:603–609, 2000. Dagher R, Pham TA, Sorbara L, et al.: Molecular confirmation of Ewing sarcoma. J Pediatr Hematol/Oncol 23:221–223, 2001. Rubin 5e Suggested Readings P. 88 of 97 de Vernejoul MC, Benichou O: Human osteopetrosis and other sclerosing disorders: Recent genetic developments. Calcif Tissue Int 69:1–6, 2001. Ferrari SJ, Rizzoli R: Gene variants for osteoporosis and their pleiotropic effects in aging. Mol Aspects Med 26:145–167, 2005. Forlino A, Marini JC: Osteogenesis imperfecta: Prospects for molecular therapeutics. Mol Genet Metab 71:225–232, 2000. Fuchs B, Pritchard DJ: Etiology of osteosarcoma. Clin Orthop 397:40–52, 2002. Gallacher SJ: Paget disease of bone. Curr Opin Rheumatol 5:351–356, 1993. Gigante M, Matera MG, Seripa D, et al.: Ext-mutation analysis in Italian sporadic and hereditary osteochondromas. Int J Cancer 95:378–383, 2001. Haynes MK, Smith JA: Rheumatoid arthritis: A molecular understanding. Ann Intern Med 136:908–922, 2002. Hendy GN, D’Souza-Li L, Yang B, et al.: Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16:281–296, 2000. Horton WA, Lunstrum GP: Fibroblast growth factor receptor 23 mutations in achondroplasia and related forms of dwarfism. Rev Endocr Metabol Dis 3:381–385, 2002. Hruska KA, Teitelbaum SL: Renal osteodystrophy. N Engl J Med 333:166–174, 1995. Huvos AG: Malignant surface lesions of bone. Curr Diagn Pathol 7:247–250, 2001. Inman RD, Scofield RH: Etiopathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 6:360–370, 1994. Rubin 5e Suggested Readings P. 89 of 97 Klein MJ, Kenan S, Lewis MM: Osteosarcoma: Clinical and pathological considerations. Orthop Clin North Am 20:327–345, 1989. Kuivaniemi H, Tromp G, Prockop D: Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 9:300–315, 1997. Maiya S, Grimer RJ, Ramaswamy R, et al.: Osteosarcoma occurring in osteogenesis imperfecta tarda. Int Orthop 26:126–128, 2002. Manolagas AC, Jilka RL: Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305–311, 1995. Manolagas SD: Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137, 2000. Marcus R: Normal and abnormal bone remodeling in man. Annu Rev Med 38:129–143, 1987. McCormick G, Duncan G, Tufaro F: New perspectives in the molecular basis of hereditary bone tumors. Mol Med Today 5:481–486, 1999. Nuovo MA, Dorfman HD, Sun CC, et al.: Tumor-induced osteomalacia and rickets. Am J Surg Pathol 13:588–599, 1989. Ollier W, Barton A: Genetic approaches to the investigation of rheumatoid arthritis. Curr Opin Rheumatol 13:260–269, 2002. Qualman SJ, Morotti RA: Risk assignment in pediatric soft-tissue sarcomas: An evolving molecular classification. Oncol Rep 4:123–130, 2002. Rubin 5e Suggested Readings P. 90 of 97 Ragland BD, Bell WC, Lopez RR, et al.: Cytogenetics and molecular biology of osteosarcoma. Lab Invest 82:365–373, 2002. Ralston SH: Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87:2460–2466, 2002. Raney RB: Soft-tissue sarcoma in childhood and adolescence. Curr Oncol Rep 4:291– 298, 2002. Reddy SV, Kurihara N, Menaa C, et al.: Paget’s disease of bone: A disease of the osteoclast. Rev Endocr Metab Disord 2:195–201, 2001. Riggs BL: The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106:1203–1204, 2000. Roodman GD: Studies in Paget’s disease and their relevance to oncology. Semin Oncol 28:15–21, 2001. Salusky IB, Goodman WG: Adynamic renal osteodystrophy: Is there a problem? J Am Soc Nephrol 12:1978–1985, 2001. Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Congenital (infantile) fibrosarcoma and mesoblastoma nephroma. Can Gene Cytogene 132:1–13, 2002. Schiller AL: Diagnosis of borderline cartilage lesions of bone. Semin Diagn Pathol 2:42– 61, 1985. Scully RE, Mark EJ, McNeely WF, et al.: Case 29-2001 Oncogenic osteomalacia. N Engl J Med 345:903–908, 2001. Seufert J, Ebert K, Muller J, et al.: Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:1883–1888, 2001. Rubin 5e Suggested Readings P. 91 of 97 Sledge CB: Structure, development, and function of joints. Orthop Clin North Am 6:619– 629, 1975. Sorensen PHB, Lynch JC, Qualman SJ, et al.: PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the children’s oncology group. J Clin Oncol 20:2672– 2679, 2002. Tallini G, Dorfman H, Brys P, et al.: Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumors. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. J Pathol 196:194–203, 2002. Theoleyre S, Wittrant Y, Kwan Tat Y, et al.: The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15:457–475, 2004. Tolar J, Teitelbaum SL, Orchard PJ: Osteopetrosis. N Engl J Med 351:2839–2849, 2004. Unger S, Hecht JT: Pseudoachondroplasia and multiple epiphyseal dysplasias: New etiologic developments. Am J Med Genet 106:244–250, 2001. Weiss SW: Soft tissue sarcomas: Lessons from the past, challenges for the future. Mod Pathol 15:77–86, 2002. Chapter 27 Books Carpenter S, Karpati G: Pathology of skeletal muscle, 2nd ed. New York, Oxford University Press, 2001. DiMauro S: Mitochondrial encephalomyopathies. In: Rosenberg RN (ed): Molecular and genetic basis of neurological disease. Stoneham, UK: Butterworth, 1993:665–694. Rubin 5e Suggested Readings P. 92 of 97 Emery AEH: Duchenne muscular dystrophy, rev. ed. Oxford Monographs on Medical Genetics, vol 15. New York: Oxford University Press, 1988. Engel AG, Franzini-Armstrong C: Myology, 2nd ed. New York: McGraw-Hill, 1994. Karpati G: Structural and molecular basis of skeletal muscle diseases. Basal: ISN Neuropath Press, 2002. Mastaglia FL, Walton OF, Detchant L: Skeletal muscle pathology, 2nd ed. Edinburgh: Churchill-Livingstone, 1992. Walton JA: Disorders of voluntary muscle, 5th ed. London: Churchill-Livingstone, 1988. Review Articles Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet 3:283–291, 1993. Asbury AK, McKhann GM, McDonald WI: Diseases of the central nervous system. Clin Neurol 1:11–15, 1992. Beggs AH, Kunkel LM: Improved diagnosis of Duchenne/Becker muscular dystrophy. J Clin Invest 85:613–619, 1990. Cullen MJ, Mastaglia FL: Morphological changes in dystrophic muscle. Br Med Bull 36:145–152, 1980. DiMauro S, Bresolin E, Hays AP: Disorders of glycogen metabolism of muscle. Crit Rev Clin Neurobiol 1:83–116, 1984. DiMauro S, Trevisan C, Hays A: Disorders of lipid metabolism in muscle. Muscle Nerve 3:369–388, 1980. Rubin 5e Suggested Readings P. 93 of 97 Mastaglia FL, Ojeda VJ: Inflammatory myopathies: Part 1. Ann Neurol 17:215–227, 1985. Mastaglia FL, Ojeda VJ: Inflammatory myopathies: Part 2. Ann Neurol 17:317–323, 1985. Plotz PH, Dalakas M, Leff RL, et al.: Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis and related disorders. Ann Intern Med 111:143–157, 1989. Worton RG, Thompson MW: Genetics of Duchenne muscular dystrophy. Annu Rev Genet 22:601–629, 1988. Chapter 28 The Central Nervous System Alison MR: Cancer handbook. London: Nature Publishing Group, 2001. Clark CM, Trojanowski JQ: Neurodegenerative dementias: Clinical features and pathological mechanisms. New York: McGraw-Hill, 2000. Esiri M, Lee VM-Y, Trojanowski JQ: The neuropathology of dementia. Cambridge, MA: Cambridge University Press, 2002. Geschwind D, Gregg J: Microarrays for the neuroscience: an essential guide, Boston: MIT Press, 2002. Graham DI, Lantos PL: Greenfield’s neuropathology, 7th ed. London: Hodder Arnold Press, 2002. Kleihues P, Cavenee WK: Pathology and genetics of tumors of the nervous system, 2nd ed. Lyon, France: International Agency for Cancer Research, 2000. Rubin 5e Suggested Readings P. 94 of 97 Rosenberg RN, Prusiner SB, Di Mauro S, et al.: The molecular and genetic basis of neurological and psychiatric disease, 3rd ed. Woburn, MA: Butterworth Heineman Press, 2002. The Peripheral Nervous System Dyck PJ, Thomas PK: Peripheral neuropathy, 4th ed. Philadelphia: Elsevier Saunders, 2005. Greenberg SA, Walsh RJ: Molecular diagnosis of inheritable neuromuscular disorders. Part II: Application of genetic testing in neuromuscular disease. Muscle Nerve 31:431– 451, 2005. Klein CJ, Dyck PJ: Genetic testing in inherited peripheral neuropathies. J Periph Nerv Syst 10:77–84, 2005. Ward BA, Guttmann DH: Neurofibromatosis 1: From lab bench to clinic. Pediatr Neurol 32:221–228. Chapter 29 Eagle RC Jr: Eye pathology: An atlas and basic text. Philadelphia: WB Saunders, 1999. Garner A, Klintworth GK: Pathobiology of ocular disease: A dynamic approach, 2nd ed. New York: Marcel Dekker, 1994. Klintworth GK: The eyepathologist. www.eyepathologist.com Klintworth GK: The eye and ocular adnexa. In: Mills SE, Carter D, Greenson JK, et al. (eds). Sternberg’s diagnostic surgical pathology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004:1073–1108. Rubin 5e Suggested Readings P. 95 of 97 Klintworth GK, Eagle RC Jr: Eye and ocular adnexa. In: Damjanov I, Linder J (eds). Anderson’s pathology, 10th ed. St. Louis: Mosby, 1996:2832–2875. Klintworth GK, Garner A, Cameron JD, et al.: Garner and Klintworth’s pathobiology of ocular disease: A dynamic approach, 3rd ed. New York: Taylor & Francis Books, 2007. Spencer WH: Ophthalmic pathology: An atlas and textbook, 4th ed. Philadelphia: WB Saunders, 1996. Yanoff M, Fine BS: Ocular pathology, 5th ed. St. Louis: Mosby-Year Book, 2002. Chapter 30 Books Bibbo M: Comprehensive cytopathology, 2nd ed. Philadelphia: WB Saunders, 1997. DeMay RM: The art and science of cytopathology. Chicago: ASCP Press, 1996. Koss LG, Melamed MR: Koss’ diagnostic cytology and its histopathologic bases, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2005. Koss LG, Woyke S, Olszewski W: Aspiration biopsy: Cytologic interpretation and histologic bases, 2nd ed. Tokyo: Igaku-Shoin, 1992. Silverberg SG, DeLellis RA, Frable WJ, et al.: Silverberg’s principles and practice of surgical pathology and cytopathology, 4th ed. New York: Churchill-Livingstone, 2006. Solomon D, Nayar R: The Bethesda System for repoting cervical cytology: Definitions, criteria and explanatory notes, 2nd ed. New York: Springer-Verlag, 2004. Review Articles Rubin 5e Suggested Readings P. 96 of 97 Baloch ZW, LiVolsi VA: Fine-needle aspiration of thyroid nodules: Past, present and future. Endocr Pract 10:234–241, 2004. Caraway NP: Strategies to diagnose lymphoproliferative disorders by fine-needle aspiration by using ancillary studies. Cancer 105:432–442, 2005. Davey E, Barratt A, Irwig L, et al.: Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: A systematic review. Lancet 367:122–132, 2006 Ehya H: Effusion cytology. Clin Lab Med 11:443–467, 1991. Ehya H, Young NA: Cytologic approach to tumors of the tracheobronchial tree. Chest Surg Clin N Am 13:41–62, 2003. Hajdu SI: Cytology from antiquity to Papanicolaou. Acta Cytol 21:668–676, 1977. Holcomb K, Runowicz CD: Cervical cancer screening. Surg Oncol Clin N Am 14:777– 797, 2005. Jhala NC, Jhala DN, Chhieng DC, et al.: Endoscopic ultrasound-guided fine-needle aspiration. A cytopathologist’s perspective. Am J Clin Pathol 120:351–367, 2003. Jorgensen JL: State of the Art Symposium: Flow cytometry in the diagnosis of lymphoproliferative disorders by fine-needle aspiration. Cancer 105:443–451, 2005. Lau SK, McKee GT, Weir MM, et al.: The negative predicative value of breast fine- needle aspiration biopsy: The Massachusetts General Hospital experience. Breast J 10:487–491, 2004. Oliveira AM, French CA: Applications of fluorescence in situ hybridization in cytopathology: A review. Acta Cytol 49:587–594, 2005. Rubin 5e Suggested Readings P. 97 of 97 Singh HK, Kilpatrick SE, Silverman JF: Fine needle aspiration biopsy of soft tissue sarcomas: Utility and diagnostic challenges. Adv Anat Pathol 11:24–37, 2004. Solomon D, Davey D, Kurman R, et al.: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287:2114–2119, 2002. Zakowski MF: Fine-needle aspiration cytology of tumors: Diagnostic accuracy and potential pitfalls. Cancer Invest 12:505–515, 1994.